info icon

Parodontitis, under 40 years

K11_PARODON_EARLY

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Pre-conditions: EVENT_AGE<40

Registry filters:

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

4553

6. Filter based on genotype QC (FinnGen only)

4553

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 4553 2812 1741
Unadjusted period prevalence (%) 0.89 0.96 0.77
Median age at first event (years) 33.31 32.84 34.07

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3779
Matched controls
37789
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K05.31
ICD-10 Finland
Periodontitis pronounced
104.7
323.0
1243
176
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
4.7
323.0
1719
5676
K05.30
ICD-10 Finland
Periodontitis complex
423.4
323.0
2926
306
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
3.8
316.6
2170
9952
SAA02
NOMESCO Finland
Basic examination of mouth
4.6
264.5
3332
23383
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.1
236.9
2189
11562
K02.1
ICD-10 Finland
Caries of dentine
3.5
233.0
3020
20145
WX110
NOMESCO Finland
Local anesthesy
3.5
205.5
3186
22844
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
7.3
199.3
513
792
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.7
179.2
2465
15481
SAA03
NOMESCO Finland
Extended examination of mouth
2.6
171.3
2091
12111
SAA01
NOMESCO Finland
Simple examination of mouth
3.2
170.9
3215
24120
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.8
169.3
2905
20430
WX290
NOMESCO Finland
Other blockade of nerve
2.6
164.8
2580
17027
SDA02
NOMESCO Finland
Parodonthologic therapy
2.6
156.5
1673
8830
EBA00
NOMESCO Finland
Extraction of tooth
2.5
146.0
1727
9526
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.4
135.5
2482
16850
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
2.4
133.9
2587
17986
WZA90
NOMESCO Finland
Other doctors statement
2.6
133.0
1253
6012
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.7
121.0
1003
4423
SDA12
NOMESCO Finland
Treatment of complicated periodontal disease
46.3
119.4
147
33
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.8
117.1
555
1639
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
3.6
106.5
544
1701
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
2.4
106.0
1143
5756
K05.3
ICD-10 Finland
Chronic periodontitis
8.8
98.6
220
264
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.2
97.6
1485
8726
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.5
93.4
868
3997
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
90.1
1317
7537
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.0
86.3
2060
14288
SBA00
NOMESCO Finland
Microbiological examinations
10.2
83.5
170
173
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
2.1
82.5
1323
7802
KMAK
NOMESCO Finland
NA
1.9
71.9
2433
18556
D82
ICPC
Teeth/gum disease
1.9
70.7
1693
11432
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.3
68.0
770
3838
SDA
NOMESCO Finland
Treatment of periodontitis and gingival lesions
47.1
67.9
83
18
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.8
65.9
478
1873
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
2.1
65.7
951
5275
-1
NOMESCO Finland
NA
1.8
64.8
1637
11142
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.8
59.7
1393
9154
K05.4
ICD-10 Finland
Periodontosis
152.4
57.0
60
*
SAAPA
NOMESCO Finland
NA
29.1
56.8
77
27
SGA01
NOMESCO Finland
Tooth opening as first aid
2.0
55.3
815
4507
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.8
54.5
1292
8470
K05.38
ICD-10 Finland
Other chronic periodontitis
11.9
53.6
100
86
D19
ICPC
Teeth/gum symptom/complaint
1.8
52.3
1123
7100
Z01.2
ICD-10 Finland
Dental examination
1.7
51.3
1710
12375
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.9
50.6
219
584
EBA15
NOMESCO Finland
Extraction of large number of teeth
6.8
50.2
130
196
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.1
49.3
651
3424
K02.0
ICD-10 Finland
Caries limited to enamel
1.9
48.5
851
4994
EBA10
NOMESCO Finland
Surgical removal of tooth
1.9
47.9
920
5571
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.1
43.5
259
885
C03CA01
ATC
furosemide; systemic
3.3
42.4
228
725
SPAT1283
SPAT
Restricted health certificate
1.7
42.2
1254
8639
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.0
41.9
97
124
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
8.2
41.6
95
119
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.3
40.8
214
667
K04.1
ICD-10 Finland
Necrosis of pulp
2.2
40.6
448
2160
ECA50
NOMESCO Finland
Parodontal operation
27.9
40.3
55
20
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
2.2
40.0
430
2048
L04AA06
ATC
mycophenolic acid; systemic
6.7
39.9
104
159
127
Kela drug reimbursment
Transplant complication
7.3
39.5
97
136
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
2.1
38.7
506
2627
A11CC03
ATC
alfacalcidol; systemic
7.2
38.6
96
137
K04.0
ICD-10 Finland
Pulpitis
2.0
38.4
563
3061
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.5
37.6
313
1309
P01AB01
ATC
metronidazole; oral, rectal
1.6
37.4
1221
8561
Z94.0
ICD-10 Finland
Kidney transplant status
8.4
37.1
83
101
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.7
36.5
987
6559
EMAK
NOMESCO Finland
NA
3.0
36.2
221
768
SPAT1310
SPAT
Counselling related to known health issue
1.6
35.8
1123
7767
TK800
NOMESCO Finland
Hemodialysis
6.8
35.3
91
137
SFA40
NOMESCO Finland
Replacement of krone of tooth
2.1
35.2
424
2119
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.2
35.1
67
61
K05.39
ICD-10 Finland
Periodontitis UNS
8.6
35.0
77
91
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
9.0
35.0
75
85
SGC10
NOMESCO Finland
Covering pulpa of tooth
1.9
34.8
551
3074
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.6
34.0
1075
7429
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.2
32.8
182
592
A12AA04
ATC
calcium carbonate; oral
9.7
32.3
66
69
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
2.1
32.1
387
1934
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.2
32.1
348
1657
N05AH04
ATC
quetiapine; oral
1.7
30.0
746
4796
SPAT1263
SPAT
Sampling
1.5
29.8
1576
12215
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.9
29.5
476
2663
ECA55
NOMESCO Finland
Complicated parodontal operation
24.4
29.2
41
17
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.9
29.1
435
2364
N07BA03
ATC
varenicline; oral
2.5
29.1
234
961
137
Kela drug reimbursment
Uraemia requiring dialysis
10.1
28.6
57
57
B03XA02
ATC
darbepoetin alfa; parenteral
8.2
28.5
64
79
SDA13
NOMESCO Finland
Treatment of complicated periodontal disease, extensive and demanding
49.0
28.4
34
7
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.7
28.2
199
756
K03.66
ICD-10 Finland
Tooth plaque
2.5
28.1
231
959
K04.08
ICD-10 Finland
Other specified pulpit
2.0
28.1
373
1937
SDA10
NOMESCO Finland
Parodonthologic therapy of advnaced and complicated changes of alveolar bone
31.1
28.1
37
12
Z49.0
ICD-10 Finland
Preparatory care for dialysis
11.7
28.1
52
45
B05DA
ATC
Isotonic solutions
11.2
28.0
53
48
HMAK
NOMESCO Finland
NA
1.8
28.0
563
3391
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.0
27.8
390
2066
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.5
27.7
61
73
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
27.7
393
2094
Z49.2
ICD-10 Finland
Other dialysis
12.0
27.4
50
42
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
27.3
839
5699
SPAT1301
SPAT
No procedures
1.6
27.0
996
7075
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
5.5
26.8
80
147
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
1.8
26.8
502
2953
N02BE01
ATC
paracetamol; systemic, rectal
1.5
26.7
2733
24031
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
10.5
26.7
52
50
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.4
26.6
133
401
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.3
25.9
256
1168
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
7.9
25.7
59
76
A03
ICPC
Fever
1.6
25.4
846
5845
K08.3
ICD-10 Finland
Retained dental root
2.7
25.2
178
678
C08CA01
ATC
amlodipine; oral
2.2
25.1
281
1356
V03AE02
ATC
sevelamer; oral
15.3
25.0
41
27
SPAT1312
SPAT
General health counselling
1.5
25.0
1254
9506
N06AB04
ATC
citalopram; systemic
1.7
24.9
630
4050
205
Kela drug reimbursment
Chronic hypertension
3.1
24.8
142
472
SPAT1262
SPAT
Handing over of treatment supplies
1.9
24.8
377
2058
S18
ICPC
Laceration/cut
1.5
24.8
970
6963
K03.64
ICD-10 Finland
Dental calculus supragingival
1.5
24.3
1207
9114
WKPAL
NOMESCO Finland
NA
4.7
24.1
83
180
TK820
NOMESCO Finland
Peritoneal dialysis
13.8
24.0
41
30
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
10.3
24.0
47
46
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
24.0
421
2418
K06.18
ICD-10 Finland
Another gingival hyperplasia
20.8
23.8
35
17
SGA05
NOMESCO Finland
Very demanding and lengthy opening and dilatation of root canal of tooth
2.0
23.5
303
1551
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
12.1
23.2
42
35
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.7
23.2
493
3008
ECA70
NOMESCO Finland
Regenerative parodontal operation or gingiva and alveolus transplantation
16.2
23.1
37
23
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
1.7
23.0
536
3361
A10AE04
ATC
insulin glargine; parenteral
2.1
22.6
257
1249
WX002
NOMESCO Finland
Sedation and analgesia
1.8
22.6
388
2210
N18.0
ICD-10 Finland
End-stage renal disease
8.8
22.5
48
55
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.1
22.2
123
402
N07BB01
ATC
disulfiram; oral
2.5
22.1
179
736
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
21.8
239
1143
K05.32
ICD-10 Finland
Periodontitis NOS
1.6
21.6
587
3834
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.9
21.5
335
1845
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
21.3
486
3023
K05.18
ICD-10 Finland
Chronic gingivitis
2.2
21.3
227
1072
SPAT1216
SPAT
Assessment of functional ability
2.1
21.3
238
1148
Z72.0
ICD-10 Finland
Tobacco use
3.2
21.2
113
359
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
21.1
689
4711
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
21.1
127
438
R74
ICPC
Upper respiratory infection acute
1.4
21.1
1453
11609
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.9
20.9
330
1825
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.1
20.7
234
1133
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
20.7
608
4049
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
20.6
539
3479
C09AA02
ATC
enalapril; systemic
2.4
20.4
178
762
WZA00
NOMESCO Finland
Short statement of of health and health related matters
2.0
20.4
275
1433
B05DB
ATC
Hypertonic solutions
9.6
20.3
41
43
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.5
20.0
94
272
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.3
19.9
189
845
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
3.0
19.9
120
414
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.1
19.8
63
126
SPAT1240
SPAT
Therapeutic discussion
1.6
19.7
608
4094
K10.3
ICD-10 Finland
Alveolitis of jaws
2.1
19.4
220
1066
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.6
19.4
507
3270
SGB20
NOMESCO Finland
Filling of root of tooth with 2 root channels
1.9
19.4
279
1488
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
5.3
19.3
59
113
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
19.1
271
1437
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.5
19.1
45
61
SPAT1254
SPAT
Administration of medicine
1.7
19.1
387
2319
D11
ICPC
Diarrhoea
1.6
19.0
545
3601
A02BC02
ATC
pantoprazole; systemic
1.4
18.9
1550
12688
M54.5
ICD-10 Finland
Low back pain
1.4
18.8
1062
8133
K04.09
ICD-10 Finland
Pulpit UNS
2.2
18.8
202
958
S10
ICPC
Boil/carbuncle
2.2
18.8
189
869
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
18.8
519
3397
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
18.5
1249
9882
C10AA01
ATC
simvastatin; oral
2.2
18.3
193
907
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
5.7
18.1
52
93
D10
ICPC
Vomiting
1.7
17.8
391
2400
N01
ICPC
Headache
1.6
17.7
518
3439
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.9
17.7
250
1328
R05
ICPC
Cough
1.5
17.7
691
4908
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
17.6
362
2180
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
14.6
17.6
29
20
T89
ICPC
Diabetes insulin dependent
2.1
17.4
203
996
N18.8
ICD-10 Finland
Other chronic renal failure
5.1
17.4
55
110
N05AH03
ATC
olanzapine; systemic
1.8
17.3
287
1610
L17
ICPC
Foot/toe symptom/complaint
1.5
17.2
593
4088
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.3
17.1
86
263
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.8
17.0
292
1656
SPAT1260
SPAT
Consultation of another employee
1.6
17.0
518
3470
196
Kela drug reimbursment
Paricalcitol and cinacalcet
11.6
17.0
31
27
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
16.9
602
4183
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
10.4
16.6
32
31
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
16.4
1417
11613
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
2.4
16.4
146
634
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.8
16.3
307
1795
C07AG02
ATC
carvedilol; oral
5.4
16.1
48
90
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
3.4
16.0
77
229
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
16.0
431
2798
VALMI
NOMESCO Finland
NA
1.4
15.9
980
7583
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.1
15.8
189
940
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
15.7
2788
25438
M79.6
ICD-10 Finland
Pain in limb
1.4
15.6
916
7023
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
15.6
205
1060
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
15.5
307
1827
L03
ICPC
Low back symptom/complaint
1.4
15.4
749
5546
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
38.2
15.4
19
5
T90
ICPC
Diabetes non-insulin dependent
2.0
15.2
209
1098
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.1
15.2
183
912
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.6
15.2
108
418
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.0
15.1
209
1100
V03AE01
ATC
polystyrene sulfonate; oral
6.6
15.0
38
58
R11
ICD-10 Finland
Nausea and vomiting
1.8
15.0
271
1565
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.3
15.0
145
656
K03.00
ICD-10 Finland
Approximal wear
2.1
14.9
176
869
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
10.1
14.9
29
29
N02AX02
ATC
tramadol; systemic, rectal
1.4
14.9
827
6269
N06AX21
ATC
duloxetine; oral
1.7
14.9
301
1800
C02AC05
ATC
moxonidine; oral
5.1
14.8
46
91
XCK10
NOMESCO Finland
Photography of fundus of eye
2.0
14.7
192
989
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
14.6
1291
10563
K05.20
ICD-10 Finland
Periodontal abscess without fistula
5.4
14.5
43
81
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
14.5
675
4951
N06AX11
ATC
mirtazapine; oral
1.4
14.4
852
6527
K05.1
ICD-10 Finland
Chronic gingivitis
1.7
14.4
283
1682
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
14.3
395
2579
ECB00
NOMESCO Finland
Suture of gingiva
2.4
14.1
118
499
N05BA01
ATC
diazepam; systemic, rectal
1.7
14.1
285
1704
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
14.0
220
1213
ZX120
NOMESCO Finland
Intravenous
1.9
14.0
203
1090
H3603, E103
ICD-10 Finland
NA
3.2
13.9
74
238
N03AG01
ATC
valproic acid; systemic, rectal
1.8
13.9
225
1253
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.0
13.9
181
931
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
13.9
280
1676
SPAT1153
SPAT
Removal of sutures
1.4
13.9
629
4582
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
13.8
174
882
D01
ICPC
Abdominal pain/cramps general
1.6
13.8
408
2709
ECA30
NOMESCO Finland
Excision of lesion of gingiva
5.0
13.8
43
86
SDC30
NOMESCO Finland
Strong parodontological fixation of 2-3 teeth
20.1
13.8
20
10
SDC10
NOMESCO Finland
Parodontological fixation
10.5
13.7
26
25
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
13.6
13.7
23
17
SBB10
NOMESCO Finland
Teeth copy
1.8
13.6
245
1415
H01
ICPC
Ear pain/earache
1.5
13.6
431
2903
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.6
13.5
393
2594
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.2
13.5
71
227
SDC40
NOMESCO Finland
Strong parodontological fixation of 4-6 teeth
34.1
13.5
17
5
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.1
13.5
161
802
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.3
13.4
67
206
N05AA02
ATC
levomepromazine; systemic
2.3
13.4
121
530
B18.2
ICD-10 Finland
Chronic viral hepatitis C
2.7
13.4
89
331
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.8
13.4
44
93
K05.11
ICD-10 Finland
Gingivitis (chronic) hyperplastic
6.8
13.4
33
49
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.8
13.4
244
1412
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
13.4
134
618
C10AA05
ATC
atorvastatin; oral
1.8
13.3
228
1296
A05
ICPC
Feeling ill
1.7
13.2
285
1737
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
2.7
13.2
88
329
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
9.7
13.2
26
27
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
13.1
226
1287
L04AD01
ATC
ciclosporin; systemic
3.2
13.1
67
210
N05BA04
ATC
oxazepam; oral
1.4
13.1
694
5202
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
13.1
149
728
C09AA05
ATC
ramipril; oral
2.0
13.0
170
876
N25.0
ICD-10 Finland
Renal osteodystrophy
28.4
12.9
17
6
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.4
12.9
61
180
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.5
12.9
514
3645
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
4.0
12.9
51
130
N05AX12
ATC
aripiprazole; systemic
1.8
12.9
234
1354
L02
ICPC
Back symptom/complaint
1.6
12.8
328
2095
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
32.1
12.6
16
5
Z00.0
ICD-10 Finland
General medical examination
1.5
12.5
536
3857
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
12.5
211
1192
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.2
12.5
123
564
L12
ICPC
Hand/finger symptom/complaint
1.5
12.4
413
2813
T74.1
ICD-10 Finland
Physical abuse
2.2
12.4
127
590
TK810
NOMESCO Finland
Hemofiltration
7.6
12.4
28
37
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.7
12.4
290
1811
EBA30
NOMESCO Finland
Excision of root of tooth
2.4
12.4
108
466
AA1AD
NOMESCO Finland
CT of head and brain
1.6
12.3
349
2289
K04.62
ICD-10 Finland
Periradicular abscess with fistula to mouth
3.0
12.3
71
242
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
14.4
12.3
20
14
N19
ICD-10 Finland
Unspecified kidney failure
5.9
12.2
33
56
SDD01
NOMESCO Finland
Treatment of periodontal bite, restricted
9.7
12.2
24
25
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
12.2
128
602
WZC30
NOMESCO Finland
Teaching
1.7
12.2
239
1419
N06AX16
ATC
venlafaxine; oral
1.5
12.1
489
3472
ZXA05
NOMESCO Finland
Left side
1.5
12.1
376
2521
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
7.8
12.1
27
35
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
12.1
150
759
T84.62
ICD-10 Finland
Osteitis associated with dental implants
18.1
12.0
18
10
L28
ICPC
Limited function/disability (L)
1.8
12.0
194
1082
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
8.7
12.0
25
29
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.7
12.0
278
1732
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
12.0
203
1152
R51.80
ICD-10 Finland
Headache
1.4
11.9
567
4160
S29
ICPC
Skin symptom/complaint other
1.5
11.9
401
2739
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.1
11.9
140
695
A10AE05
ATC
insulin detemir; parenteral
1.9
11.9
166
882
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
11.8
394
2690
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.2
11.7
60
189
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
11.7
398
2724
K02.8
ICD-10 Finland
Other dental caries
2.6
11.7
86
341
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
11.7
441
3091
SPAT1308
SPAT
Sexual health counselling
1.3
11.7
918
7331
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
11.7
311
2008
CKC12
NOMESCO Finland
Photocoagulation of retina
2.4
11.6
98
418
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.7
11.5
224
1324
R4110
NOMESCO Finland
Physiotherapy
1.4
11.5
538
3932
C08CA13
ATC
lercanidipine; oral
2.7
11.5
78
296
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
9.2
11.5
23
25
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
11.4
1072
8775
J01FF01
ATC
clindamycin; systemic
1.4
11.4
695
5327
SFA00
NOMESCO Finland
Small filling
1.5
11.4
365
2468
N05AX08
ATC
risperidone; systemic
1.7
11.3
226
1350
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.2
11.3
112
514
M05BA04
ATC
alendronic acid; oral
4.2
11.3
42
102
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
11.2
1020
8313
K05.28
ICD-10 Finland
Another acute periodontitis
4.8
11.1
36
76
XPX08
NOMESCO Finland
Intraoperative flow measurement
20.1
11.1
16
8
SPAT1360
SPAT
Extensive global examination
1.9
11.1
153
806
ZXA00
NOMESCO Finland
Right side
1.5
11.1
393
2714
SPE01
NOMESCO Finland
Mucosa-supported partial denture
8.0
11.1
24
30
SBA10
NOMESCO Finland
Measurement of excretion of saliva
4.8
11.0
35
73
N05CD07
ATC
temazepam; oral
2.3
10.9
96
417
C09CA01
ATC
losartan; oral
1.8
10.9
181
1018
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
3.9
10.9
44
115
K05.08
ICD-10 Finland
Another acute gingivitis
2.2
10.9
110
512
K04.00
ICD-10 Finland
Hyperemia of pulp
1.8
10.9
190
1089
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
10.9
396
2750
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
10.9
327
2179
V03AE03
ATC
lanthanum carbonate; oral
7.8
10.8
24
31
T84.60
ICD-10 Finland
Gingivitis associated with dental implants
11.9
10.8
19
16
H43.1
ICD-10 Finland
Vitreous haemorrhage
3.4
10.8
51
152
K02.9
ICD-10 Finland
Dental caries, unspecified
2.9
10.8
65
230
A10AA01
ATC
NA
2.0
10.7
132
668
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
3.5
10.7
49
143
A46
ICD-10 Finland
Erysipelas
1.8
10.7
188
1080
P06
ICPC
Sleep disturbance
1.5
10.7
326
2180
SPA47
NOMESCO Finland
Precision impression for denture
6.7
10.6
26
39
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
10.6
140
728
5AB14
NOMESCO Finland
NA
12.9
10.6
18
14
N06AB06
ATC
sertraline; oral
1.5
10.6
407
2861
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.6
10.6
297
1945
K05.21
ICD-10 Finland
Periodontal abscess with fistula
6.3
10.6
27
43
K65.0
ICD-10 Finland
Acute peritonitis
5.3
10.6
31
59
Z71.8
ICD-10 Finland
Other specified counselling
1.3
10.5
866
6947
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.7
10.5
71
269
H05BX01
ATC
cinacalcet; oral
10.0
10.5
20
20
P17
ICPC
Tobacco abuse
3.0
10.5
57
189
P29
ICPC
Psychological sympt/compl other
1.6
10.5
294
1927
A10BA02
ATC
metformin; oral
1.6
10.4
292
1912
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
10.4
876
7051
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.4
10.3
446
3205
WX872
NOMESCO Finland
Intensive care
2.5
10.3
77
308
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
10.3
436
3126
K06.10
ICD-10 Finland
Gingival fibromatosis
23.4
10.2
14
6
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
23.4
10.2
14
6
L01
ICPC
Neck symptom/complaint
1.5
10.2
395
2781
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.7
10.1
66
246
WW200
NOMESCO Finland
Immunization
2.3
10.1
93
414
N05CF01
ATC
zopiclone; oral
1.4
10.1
563
4242
SPE02
NOMESCO Finland
Metal-framed partial denture
11.3
10.0
18
16
M79.1
ICD-10 Finland
Myalgia
1.5
10.0
395
2790
WX402
NOMESCO Finland
General anaesthesia
1.4
10.0
430
3091
D09
ICPC
Nausea
1.7
9.9
192
1137
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.9
9.9
144
779
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
16.7
9.9
15
9
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
16.7
9.9
15
9
SDA14
NOMESCO Finland
Treatment of complicated periodontal disease, extensive and very demanding
26.1
9.8
13
5
N03AX16
ATC
pregabalin; oral
1.4
9.8
413
2957
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.0
9.8
116
580
C07AB07
ATC
bisoprolol; oral
1.4
9.8
481
3545
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.6
9.8
248
1584
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
9.5
9.7
19
20
SXC03
NOMESCO Finland
Other oral or dental procedure
3.4
9.7
45
133
T82
ICPC
Obesity
1.9
9.7
130
680
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.9
9.7
132
695
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.0
9.7
126
653
N03AX09
ATC
lamotrigine; oral
1.7
9.7
218
1348
A10AA02
ATC
NA
1.9
9.7
128
669
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
9.5
403
2885
K12.2
ICD-10 Finland
Cellulitis and abscess of mouth
3.4
9.5
44
130
R21
ICPC
Throat symptom/complaint
1.3
9.5
1032
8576
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
9.5
3308
31627
WX892
NOMESCO Finland
Monitored bed care
1.9
9.5
143
782
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
9.5
100
476
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.3
9.5
46
141
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
1.5
9.5
372
2626
N02AA05
ATC
oxycodone; systemic
1.9
9.5
136
729
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.7
9.5
206
1261
SXC05
NOMESCO Finland
Other oral or dental procedure
1.7
9.5
189
1128
K08.80
ICD-10 Finland
Toothache NOS
1.6
9.4
275
1819
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.4
9.4
493
3673
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
9.4
992
8215
R07
ICPC
Sneezing/nasal congestion
1.5
9.4
314
2145
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
5.3
9.3
27
51
EB1WA
NOMESCO Finland
NA
4.4
9.3
32
73
P74
ICPC
Anxiety disorder/anxiety state
1.7
9.3
211
1307
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
9.3
221
1390
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
9.3
405
2917
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
9.3
150
839
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
2.8
9.3
56
200
PARO
NOMESCO Finland
NA
8.7
9.3
19
22
K05.2
ICD-10 Finland
Acute periodontitis
4.9
9.3
29
60
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.5
9.3
75
1451
XCH00
NOMESCO Finland
Eye pressure measurement
2.8
9.2
58
209
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.0
9.2
110
552
I50.9
ICD-10 Finland
Heart failure, unspecified
3.5
9.2
41
118
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
9.2
100
484
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
13.7
9.2
15
11
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
9.1
178
1059
P15
ICPC
Chronic alcohol abuse
2.1
9.1
94
444
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
11.5
9.1
16
14
TKC20
NOMESCO Finland
Catheterisation of bladder
2.1
9.0
97
467
M25.5
ICD-10 Finland
Pain in joint
1.3
9.0
729
5813
SPAT1307
SPAT
Psychosocial counselling and guidance
1.4
9.0
380
2719
WX110
SPAT
NA
1.8
9.0
161
932
L04AA05
ATC
[U] tacrolimus; systemic
15.6
9.0
14
9
A29
ICPC
General symptom/complaint other
1.6
9.0
226
1441
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.4
9.0
73
309
SPAT1281
SPAT
Other administrative function
1.6
8.9
233
1499
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
2.4
8.9
72
303
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
18.6
8.9
13
7
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
2.9
8.9
52
181
WX704
NOMESCO Finland
Intubation
1.7
8.9
165
964
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
1.9
8.9
128
690
L84
ICPC
Back syndrome without radiat pain
2.0
8.9
117
608
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
12.5
8.9
15
12
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
12.5
8.9
15
12
Z06
ICPC
Unemployment problem
3.6
8.8
38
107
F29
ICD-10 Finland
Unspecified nonorganic psychosis
1.6
8.8
206
1292
TLOPK
NOMESCO Finland
NA
6.3
8.8
22
35
ULA02
NOMESCO Finland
Kolposcopy
1.4
8.7
368
2634
P03
ICPC
Feeling depressed
1.4
8.7
474
3551
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
5.9
8.7
23
39
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.2
8.7
87
407
SDPHK
NOMESCO Finland
NA
50.1
8.7
10
*
H05BX02
ATC
paricalcitol; systemic
50.1
8.7
10
*
H13
ICPC
Plugged feeling ear
1.5
8.7
281
1902
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
3.1
8.6
46
152
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
8.6
234
1519
EAB10
NOMESCO Finland
Excision and repair of frenum of lip
8.2
8.6
18
22
RTGBW
NOMESCO Finland
NA
10.0
8.5
16
16
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
2.6
8.5
60
236
ZXA10
NOMESCO Finland
Bilateral
1.5
8.5
333
2352
E66.8
ICD-10 Finland
Other obesity
1.8
8.5
152
881
H04AA01
ATC
glucagon; nasal, parenteral
1.7
8.5
156
914
P19
ICPC
Drug abuse
2.3
8.5
75
332
K07.60
ICD-10 Finland
Snapping jaw
1.6
8.4
191
1183
F41.09
ICD-10 Finland
UNS Panic Syndrome
1.7
8.4
159
937
C08CA02
ATC
felodipine; oral
3.1
8.4
44
144
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
2.5
8.4
61
242
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.8
8.4
50
178
F10.24
ICD-10 Finland
Alcohol depence active use
2.8
8.3
51
185
SPAT1097
SPAT
Recording of ECG
1.7
8.3
185
1142
Z72.2
ICD-10 Finland
Drug use
2.8
8.3
50
179
K05.0
ICD-10 Finland
Acute gingivitis
2.0
8.3
102
516
R06.0
ICD-10 Finland
Dyspnoea
1.4
8.3
443
3309
G47.3
ICD-10 Finland
Sleep apnoea
1.4
8.3
341
2430
N03AX12
ATC
gabapentin; oral
1.5
8.2
276
1883
ECA10
NOMESCO Finland
Incision of gingiva
2.9
8.2
47
161
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.8
8.1
49
176
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.6
8.1
204
1304
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
2.3
8.1
70
307
SPA02
NOMESCO Finland
Preparation for dental prosthetics
3.5
8.0
35
100
SFC00
NOMESCO Finland
Pillar of fillings material
2.7
8.0
52
195
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
2.5
8.0
59
237
B03XA01
ATC
erythropoietin; parenteral
6.3
8.0
20
32
SPAT1211
SPAT
Application of soft bandage
1.6
8.0
196
1245
A01
ICPC
Pain general/multiple sites
1.7
8.0
173
1060
K07.24
ICD-10 Finland
Open bite
2.3
7.9
66
284
SPAT1227
SPAT
Substance abuse rehabilitation
3.0
7.9
42
139
K85
ICPC
Elevated blood pressure
1.8
7.9
127
709
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.5
7.9
58
231
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.1
7.9
86
417
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
7.9
176
1088
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
3.2
7.9
39
123
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.2
7.9
28
67
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.6
7.8
54
208
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
7.8
157
943
L04AX01
ATC
azathioprine; systemic
1.7
7.8
143
837
SPAT1265
SPAT
Breathalyser
2.8
7.8
47
169
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
2.8
7.8
46
163
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
7.8
214
1396
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.1
7.8
83
401
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
7.8
156
937
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.1
7.7
82
392
H3601, E103
ICD-10 Finland
NA
2.5
7.7
60
247
D06
ICPC
Abdominal pain localized other
1.5
7.7
261
1786
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
2.3
7.6
64
277
SPAT1210
SPAT
Application of cast or individual aid
2.0
7.6
99
514
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
2.3
7.6
69
309
J01DB01
ATC
cefalexin; oral
1.2
7.6
2803
26397
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
4.4
7.6
26
60
R50.9
ICD-10 Finland
Fever, unspecified
1.4
7.6
382
2826
Z25
ICPC
Assault/harmful event problem
2.7
7.6
50
190
N05AF03
ATC
chlorprothixene; systemic
2.1
7.6
83
402
N05AB03
ATC
perphenazine; systemic, rectal
2.0
7.6
92
465
N05BA12
ATC
alprazolam; oral
1.6
7.6
215
1415
A02BC01
ATC
omeprazole; systemic
1.3
7.6
533
4163
N05AH02
ATC
clozapine; systemic
1.9
7.5
99
519
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
7.5
231
1546
TUPKY
NOMESCO Finland
NA
2.9
7.5
44
155
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
5.7
7.5
20
35
TQW80
NOMESCO Finland
Local dermatologic skincare
2.4
7.5
57
235
Z72.1
ICD-10 Finland
Alcohol use
2.9
7.5
43
148
S22
ICPC
Nail symptom/complaint
1.8
7.5
116
644
K07.23
ICD-10 Finland
Deep bite
2.2
7.5
70
317
N06AB03
ATC
fluoxetine; oral
1.5
7.5
288
2027
K05
ICD-10 Finland
Gingivitis and periodontal diseases
2.9
7.5
43
149
F40.2
ICD-10 Finland
Specific (isolated) phobias
2.7
7.5
48
179
JAETT
NOMESCO Finland
NA
4.8
7.4
23
48
F43.1
ICD-10 Finland
Post-traumatic stress disorder
1.7
7.4
136
797
S22.3
ICD-10 Finland
Fracture of rib
1.9
7.4
108
587
TQX20
NOMESCO Finland
Implantation of subcutaneous medicament implant
3.3
7.4
35
107
VALPA
NOMESCO Finland
NA
80.2
7.4
8
*
D02
ICPC
Abdominal pain epigastric
1.7
7.4
158
968
NHQ40
NOMESCO Finland
Amputation of toe
7.6
7.4
16
21
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
7.6
7.4
16
21
R02
ICPC
Shortness of breath/dyspnoea
1.5
7.4
254
1749
N06AB05
ATC
paroxetine; oral
1.6
7.4
180
1142
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.6
7.3
31
87
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.5
7.3
227
1524
C02CA01
ATC
prazosin; oral
9.4
7.3
14
15
ECA20
NOMESCO Finland
Biopsy of gingiva
4.9
7.3
22
45
J01AA04
ATC
lymecycline; systemic
0.7
7.2
297
4003
K04.6
ICD-10 Finland
Periapical abscess with sinus
3.3
7.1
34
105
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
7.1
241
1649
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
3.3
7.1
33
100
SPAT1192
SPAT
Gynaecological examination
1.3
7.1
602
4822
F39
ICD-10 Finland
Unspecified mood [affective] disorder
1.9
7.1
95
501
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.5
7.1
53
215
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
7.1
214
1429
F32
ICD-10 Finland
Depressive episode
1.5
7.1
220
1479
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
7.1
245
1688
SDD02
NOMESCO Finland
Treatment of periodontal bite
12.0
7.1
12
10
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
4.0
7.1
26
65
H02AB04
ATC
methylprednisolone; systemic
1.5
7.0
253
1757
P72
ICPC
Schizophrenia
2.1
7.0
72
342
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
7.0
527
4153
SPAT1104
SPAT
Monitoring of emergency patient
1.8
7.0
119
680
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.2
7.0
34
107
R60.9
ICD-10 Finland
Oedema, unspecified
2.1
7.0
70
330
RTGHF
NOMESCO Finland
NA
7.0
7.0
16
23
E10
ICD-10 Finland
Type 1 diabetes mellitus
1.9
7.0
100
540
F61.0
ICD-10 Finland
Mixed personality disorders
2.0
7.0
81
404
F17.2
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, dependence syndrome
3.7
6.9
28
76
F41.00
ICD-10 Finland
Moderate panic disorder
1.9
6.9
92
486
S01
ICPC
Pain/tenderness of skin
1.9
6.9
92
486
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
5.8
6.9
18
31
A10AE06
ATC
insulin degludec; parenteral
1.8
6.9
111
625
XF612
NOMESCO Finland
Measurement of central venous pressure
13.8
6.9
11
8
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.6
6.9
22
48
PLAK2
NOMESCO Finland
NA
3.6
6.9
29
82
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.7
6.8
139
841
E10.01
ICD-10 Finland
Insulin-dependent diabetes diabetic coma with hyperglycemia
4.4
6.8
23
53
F60.9
ICD-10 Finland
Personality disorder, unspecified
2.1
6.8
74
362
LCH00
NOMESCO Finland
Vacuum aspiration of products of conception from uterus
1.8
6.8
116
667
K02.2
ICD-10 Finland
Caries of cementum
2.3
6.8
60
265
RS220
NOMESCO Finland
NA
2.5
6.8
51
208
N03AE01
ATC
clonazepam; systemic
1.7
6.8
121
705
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.5
6.8
49
198
N03AF01
ATC
carbamazepine; oral, rectal
2.0
6.8
78
391
K05.29
ICD-10 Finland
Acute periodontitis UNS
5.3
6.8
19
36
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
40.1
6.8
8
*
SAATP
NOMESCO Finland
NA
40.1
6.8
8
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.6
6.7
153
954
S04
ICPC
Lump/swelling localized
1.4
6.7
266
1882
P01
ICPC
Feeling anxious/nervous/tense
1.3
6.7
587
4723
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
2.4
6.7
54
230
K00.09
ICD-10 Finland
Lack of teeth due to lack of dental development UNS
4.1
6.7
24
59
SDC20
NOMESCO Finland
Extensive parodontological fixation
22.5
6.7
9
*
B01AB05
ATC
enoxaparin; parenteral
1.3
6.7
457
3552
WW500
NOMESCO Finland
Blood transfusion
2.0
6.7
81
413
A10BJ06
ATC
semaglutide; parenteral
2.7
6.7
43
161
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.6
6.6
174
1125
F10.25
ICD-10 Finland
Alcohol dependence continuous use
2.5
6.6
50
204
3AC01
NOMESCO Finland
NA
2.9
6.6
36
123
SPAT1395
SPAT
Health check-up of persons outside student and working life
2.2
6.6
62
284
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
5.9
6.6
17
29
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
4.6
6.6
21
46
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
1.4
6.5
273
1954
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
2.4
6.5
51
215
SPAT1058
SPAT
PEF monitoring instruction
1.6
6.5
165
1057
ECB10
NOMESCO Finland
Reconstruction of gingiva
10.0
6.5
12
12
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
6.5
435
3369
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
6.5
578
4654
Z36.8
ICD-10 Finland
Other antenatal screening
1.7
6.5
115
670
RD211
NOMESCO Finland
NA
1.9
6.5
88
469
EBB10
NOMESCO Finland
Insertion of dental implant
2.6
6.5
43
166
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
2.2
6.5
63
292
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.1
6.4
32
103
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
6.4
248
1745
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
6.4
133
807
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.3
6.4
462
3618
L02.0
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of face
2.3
6.4
55
241
H29
ICPC
Ear symptom/complaint other
1.5
6.4
190
1266
K05.22
ICD-10 Finland
Acute pericoronitis
1.4
6.4
320
2366
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
4.7
6.4
20
43
H3602, E103
ICD-10 Finland
NA
3.4
6.4
28
82
A99
ICPC
Disease/condition unspecnature/site
1.6
6.4
165
1064
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.4
6.4
49
204
P99
ICPC
Psychological disorders other
1.7
6.4
119
704
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.8
6.3
93
509
S08
ICPC
Skin colour change
1.9
6.3
81
423
321
Kela drug reimbursment
Paricalcitol and cinacalcet
8.1
6.3
13
16
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.9
6.3
34
116
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
6.3
202
1369
K07.13
ICD-10 Finland
Retrognaty, mandibular
2.2
6.3
58
265
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
1.6
6.3
169
1101
F31.8
ICD-10 Finland
Other bipolar affective disorders
1.9
6.3
89
482
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
11.0
6.3
11
10
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
6.3
115
677
C10AA04
ATC
fluvastatin; oral
4.6
6.3
20
44
K02
ICD-10 Finland
Dental caries
1.5
6.3
209
1431
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
6.3
272
1959
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
1.3
6.2
454
3559
SAHTA
NOMESCO Finland
NA
26.7
6.2
8
*
B05D
ATC
PERITONEAL DIALYTICS
26.7
6.2
8
*
N05BA06
ATC
lorazepam; systemic, sublingual
1.8
6.2
92
505
JN4AD
NOMESCO Finland
Body CT examination
2.1
6.2
62
293
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
1.9
6.2
88
476
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
6.2
467
3680
L16
ICPC
Ankle symptom/complaint
1.4
6.2
241
1702
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.0
6.2
71
355
K01.0
ICD-10 Finland
Embedded teeth
1.7
6.2
112
657
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.6
6.2
149
947
N06AB10
ATC
escitalopram; oral
1.2
6.2
781
6562
SCB02
NOMESCO Finland
Training for mouth care at home
5.0
6.2
18
36
S97
ICPC
Chronic ulcer skin
2.2
6.2
56
253
EBB15
NOMESCO Finland
Insertion of dental implant abutment
3.3
6.1
28
85
C10AA07
ATC
rosuvastatin; oral
1.6
6.1
147
933
Z94.4
ICD-10 Finland
Liver transplant status
5.7
6.1
16
28
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
6.1
91
499
J01MA12
ATC
levofloxacin; systemic
1.4
6.1
277
2014
R4190
NOMESCO Finland
Nutritional therapy
1.9
6.1
85
456
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
6.1
295
2169
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.8
6.1
93
519
L04AA01
ATC
[U] ciclosporin; systemic
2.9
6.1
35
123
SGC40
NOMESCO Finland
Restauration of tooth for rooth therapy
2.0
6.0
70
352
R60.0
ICD-10 Finland
Localized oedema
1.6
6.0
136
847
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
2.6
6.0
40
154
SPAT1363
SPAT
Health check-up performed during first study year in students of upper secondary schools, vocational schools etc.
1.3
6.0
357
2715

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1866
13348
1.67
59.04
5.4
4.6
umol/l
9.4
10.1
2.97
1758
12465
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2741
21845
1.64
54.92
7.9
6.0
u/l
71.2
69.0
3.52
2600
20598
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1299
8603
1.71
53.77
3.4
2.5
u/l
53.9
55.8
0.61
1213
7983
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
62
66
9.51
52.46
5.8
5.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
505
2512
2.14
50.40
13.8
6.3
mmol/l
1.1
1.1
3.45
480
2382
(3013826) Glucose [Moles/volume] in Serum or Plasma
2152
16444
1.59
49.02
5.5
4.0
mmol/l
6.5
6.2
7.94
1910
14158
(3042733) HLA Ab [Presence] in Serum
72
104
7.02
47.41
6.1
4.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1500
10678
1.60
45.15
10.5
5.4
mmol/l
1.2
1.2
0.50
1279
8970
(3032080) INR in Blood by Coagulation assay
1143
7611
1.67
44.97
4.6
4.2
inr
1.0
1.1
0.37
411
2859
(3009508) Creatinine [Moles/volume] in Urine
1088
7254
1.66
42.18
5.4
3.6
mmol/l
8.6
9.0
1.37
967
6426
(3020682) Albumin/Creatinine [Ratio] in Urine
746
4487
1.79
42.04
6.5
4.8
mg/mmol
22.1
15.2
1.80
573
3287
(3012516) Albumin [Mass/volume] in Urine
725
4325
1.80
42.00
5.5
3.9
mg/l
389.2
399.6
0.02
543
3101
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1345
9478
1.59
41.50
9.5
5.0
mmol/l
1.2
1.2
0.45
1238
8660
(3019550) Sodium [Moles/volume] in Serum or Plasma
3664
32382
1.67
40.10
12.6
7.5
mmol/l
139.3
139.4
4.29
3569
31265
(3023103) Potassium [Moles/volume] in Serum or Plasma
3667
32503
1.66
38.64
12.9
7.6
mmol/l
3.9
3.9
9.06
3560
31274
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
274
1177
2.41
38.60
9.7
4.0
ng/l
121.0
79.3
4.20
255
1087
(3024561) Albumin [Mass/volume] in Serum or Plasma
1409
10203
1.55
37.89
6.1
4.6
g/l
37.2
37.9
5.04
1312
9479
(40768446) Kidney Pathology biopsy report
74
139
5.40
37.52
2.5
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
330
1595
2.15
35.08
16.8
8.0
mmol/l
9.0
6.3
10.78
324
1539
(3002032) Base excess in Venous blood by calculation
328
1631
2.09
32.34
8.8
4.1
mmol/l
1.1
1.6
0.98
270
1308
(3021447) Carbon dioxide [Partial pressure] in Venous blood
329
1642
2.08
32.12
8.2
4.1
kpa
5.8
5.9
0.63
323
1577
(3018418) pH of Serum or Plasma
922
6280
1.59
31.50
8.1
3.5
ph
7.4
7.4
0.23
197
1245
(3023368) Bacteria identified in Blood by Culture
816
5453
1.60
30.06
4.5
3.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
50
80
6.31
29.94
4.2
2.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
597
3718
1.70
28.95
2.1
1.9
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
29
25
11.67
28.26
8.4
6.0
mmol/l
6.2
5.9
0.15
29
25
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3491
31277
1.50
28.02
10.5
6.7
ml/min/173m2
102.2
102.8
0.96
2770
24508
(3013707) Erythrocyte sedimentation rate by Westergren method
2708
23161
1.42
27.74
4.1
3.3
mm/h
9.0
7.2
12.80
2517
21788
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3036
26593
1.43
26.53
4.7
3.3
mmol/mol
38.5
36.4
18.27
2895
25399
(3020564) Creatinine [Moles/volume] in Serum or Plasma
4015
37246
1.66
26.23
12.6
8.0
umol/l
73.8
70.3
5.68
4015
37225
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1476
11439
1.43
26.04
3.6
3.0
u/l
29.3
29.7
0.14
1404
10882
(3000991) Gas panel - Venous blood
299
1554
1.99
26.03
12.4
8.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3585
32465
1.49
25.68
4.8
4.4
mu/l
1.8
1.9
0.25
3380
30986
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
870
6093
1.53
25.64
2.4
2.0
u/l
265.0
255.3
0.06
828
5788
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
168
698
2.46
25.46
8.5
4.8
iu/ml
315.2
996.8
1.38
36
62
(3024932) HLA-DR beta [Type]
53
105
5.10
25.39
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3178
28176
1.42
25.11
4.1
3.9
pmol/l
14.4
14.4
0.17
2943
26381
(3000850) Epithelial cells [#/volume] in Urine
798
5508
1.54
25.09
3.4
2.2
e6/l
8.3
8.2
0.06
715
4745
(3001604) Monocytes [#/volume] in Blood
2022
16662
1.38
24.51
8.0
6.0
e9/l
0.6
0.5
9.55
1817
14843
(42870588) Differential panel, method unspecified - Blood
1356
10438
1.43
24.51
7.7
6.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1089
8068
1.46
24.14
3.9
2.6
e6/l
131.0
70.7
0.25
864
5928
(3012095) Magnesium [Moles/volume] in Serum or Plasma
528
3339
1.66
23.91
4.8
3.4
mmol/l
0.8
0.8
5.44
496
3130
(3024471) HLA-A [Type]
52
107
4.90
23.86
1.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1201
9093
1.44
23.62
2.1
1.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2020
16710
1.38
23.60
8.0
6.0
e9/l
0.0
0.0
6.58
1818
14855
(3013650) Neutrophils [#/volume] in Blood by Automated count
2248
18921
1.37
23.55
11.2
8.4
e9/l
4.3
4.0
9.29
2021
16713
(3026782) Osmolality of Urine
749
5180
1.53
23.17
3.4
2.3
mosm/kgh2o
541.7
557.9
1.02
660
4368
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
390
2290
1.77
23.14
4.1
4.0
u/l
226.8
221.1
0.37
373
2179
(3013115) Eosinophils [#/volume] in Blood
2076
17337
1.36
22.43
8.6
6.3
e9/l
0.2
0.2
2.63
1917
15641
(3031040) Bacteria [#/volume] in Urine by Automated count
2654
23037
1.36
22.33
4.6
3.6
e6/l
1954.1
789.9
0.56
43
254
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1173
8954
1.42
21.72
1.7
1.6
pmol/l
97.4
99.2
0.70
641
5112
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1576
12649
1.38
21.65
2.7
2.2
nmol/l
68.0
69.9
2.15
1474
12005
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
493
3145
1.64
21.47
4.6
2.3
%
23.8
25.1
1.17
422
2723
(3010375) cycloSPORINE [Mass/volume] in Blood
52
117
4.48
21.46
22.5
26.8
ug/l
106.0
111.7
0.24
40
97
(3006504) Eosinophils/100 leukocytes in Blood
1908
15811
1.36
21.28
7.9
5.9
%
2.7
2.7
0.06
1780
14897
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
207
1016
2.09
21.09
11.6
4.0
mmol/l
23.5
24.1
1.67
196
910
(3030467) Casts [#/volume] in Urine by Automated count
979
7269
1.44
21.03
3.8
2.5
e6/l
0.2
0.2
0.14
763
5241
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1006
7512
1.44
20.94
2.6
2.1
ng/l
297.0
25.0
0.50
405
2343
(3019069) Monocytes/100 leukocytes in Blood
1916
15934
1.35
20.68
8.1
6.1
%
7.9
7.9
0.77
1804
15124
(36304419) Bacteria [Presence] in Urine
997
7447
1.43
20.68
3.7
2.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1845
15261
1.35
20.62
8.1
6.0
%
0.6
0.7
0.23
1724
14384
(3019198) Lymphocytes [#/volume] in Blood
2084
17557
1.34
20.62
7.9
5.9
e9/l
2.1
2.0
3.91
1917
15931
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
482
3098
1.62
20.32
2.7
2.7
umol/l
4.9
6.1
2.52
392
2580
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
529
3487
1.59
20.07
2.0
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1048
7941
1.42
19.97
2.6
2.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
172
808
2.17
19.64
2.9
2.2
g/l
1.3
1.2
1.28
155
711
(3037467) Urinalysis macro (dipstick) panel - Urine
2768
24426
1.34
19.51
4.9
3.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
578
3919
1.54
19.33
4.1
2.2
umol/l
14.1
15.3
3.07
544
3665
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
297
1696
1.80
19.32
1.8
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1810
15032
1.34
19.28
10.1
7.6
e9/l
0.0
0.0
0.67
1545
12385
(3004119) Hemoglobin [Mass/volume] in Venous blood
198
989
2.05
19.26
4.6
3.5
g/l
132.1
136.7
1.88
193
966
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
213
1094
1.99
19.18
4.2
2.6
kpa
5.1
5.1
0.16
197
1025
(3029937) Albumin [Presence] in Urine by Test strip
1182
9202
1.38
19.07
3.8
3.1
estimate
0.0
0.0
2.76
473
3645
(3004789) Transferrin [Mass/volume] in Serum or Plasma
527
3516
1.56
18.92
4.3
2.2
g/l
2.4
2.5
4.11
489
3258
(3021960) Folate [Moles/volume] in Serum or Plasma
679
4787
1.49
18.85
1.5
1.4
nmol/l
18.4
20.1
2.34
605
4363
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3319
30170
1.37
18.84
3.3
2.6
mmol/l
5.8
5.5
16.41
3103
28430
(3027945) Reticulocytes/100 erythrocytes in Blood
309
1806
1.76
18.58
4.1
3.1
%
1.8
1.6
1.84
283
1628
(3023520) Reticulocytes [#/volume] in Blood
219
1155
1.94
18.28
3.4
2.7
e9/l
78.7
72.3
1.24
153
804
(3018010) Neutrophils/100 leukocytes in Blood
1967
16621
1.32
18.26
7.5
5.6
%
56.8
56.0
2.79
1843
15794
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3924
36779
1.48
18.23
13.0
8.6
mg/l
18.7
19.3
0.53
3146
27502
(3009343) pH of Capillary blood
209
1086
1.97
18.21
4.1
2.6
ph
7.4
7.4
0.24
33
152
(3002030) Lymphocytes/100 leukocytes in Blood
1990
16853
1.32
18.14
7.8
5.8
%
29.6
30.4
3.13
1870
15978
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
204
1053
1.98
18.12
3.9
2.6
mmol/l
1.0
0.9
0.31
141
699
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4030
37997
1.53
18.01
9.9
7.0
u/l
28.6
27.8
0.95
3914
36941
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
57
159
3.62
17.65
1.3
1.3
u/l
66.5
56.7
0.74
49
105
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
308
1825
1.74
17.65
2.6
2.6
g/l
0.2
0.2
0.60
292
1699
(3026493) Urate [Moles/volume] in Serum or Plasma
795
5852
1.43
17.54
2.8
2.1
umol/l
1074.8
2152.3
1.08
724
5350
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
863
6457
1.42
17.36
1.7
1.5
mmol/l
1.6
1.4
3.03
741
5793
(3003396) Base excess in Arterial blood by calculation
295
1744
1.74
17.04
7.9
8.2
mmol/l
-0.0
0.4
0.56
206
1270
(3018677) aPTT in Platelet poor plasma by Coagulation assay
493
3318
1.54
16.95
3.0
2.4
s
29.4
29.2
0.54
476
3192
(3000494) Fungus identified in Specimen by Culture
493
3323
1.54
16.83
1.7
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
342
2114
1.67
16.76
3.8
3.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
363
2280
1.64
16.71
5.0
4.4
%
0.6
0.8
0.90
97
469
(3022313) Gas panel - Capillary blood
149
709
2.14
16.52
4.2
2.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
352
2202
1.65
16.46
5.1
4.5
%
0.1
0.1
0.95
94
445
(3011288) Drugs identified in Urine by Screen method
511
3497
1.52
16.24
5.3
3.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
996
7713
1.37
16.19
3.4
3.0
kg/l
1.0
1.0
1.25
131
1160
(3009261) Glucose [Presence] in Urine by Test strip
2042
17531
1.30
16.17
3.6
2.9
estimate
0.0
0.0
1.30
467
3639
(3035350) Ketones [Presence] in Urine by Test strip
2029
17413
1.30
16.08
3.6
2.9
estimate
0.0
0.0
1.34
469
3603
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
182
943
1.97
16.02
1.8
2.1
ug/l
8.2
6.0
0.52
157
820
(3007853) Bacteria identified in Skin by Aerobe culture
545
3793
1.50
15.97
1.8
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
289
1732
1.71
15.89
7.9
8.3
kpa
13.6
14.3
1.01
271
1643
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
288
1732
1.71
15.64
7.9
8.3
kpa
4.9
5.0
0.35
272
1641
(3024928) Oxygen saturation in Venous blood
100
412
2.46
15.56
5.6
3.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
469
3180
1.53
15.55
1.6
1.6
nmol/l
1069.4
1168.0
1.58
381
2491
(3020191) Ethanol [Moles/volume] in Serum or Plasma
92
367
2.54
15.33
1.5
1.6
promille
1.4
1.4
0.19
70
282
(3002179) Metamyelocytes/100 leukocytes in Blood
338
2135
1.63
15.20
4.8
4.1
%
0.3
0.5
1.80
71
354
(40761511) CBC panel - Blood by Automated count
4124
39298
1.52
15.11
11.7
8.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
403
2665
1.56
14.94
2.8
2.6
ng/l
1302.6
506.1
1.58
295
1921
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1948
16739
1.29
14.88
4.2
4.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
336
2137
1.62
14.70
5.1
4.5
%
0.0
0.0
2.77
78
390
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
901
6962
1.37
14.67
2.2
1.8
%
1.4
1.3
4.70
806
6398
(3002385) Erythrocyte distribution width [Ratio]
3557
33083
1.34
14.60
15.8
10.7
%
13.3
13.2
2.14
3501
32438
(3021601) Nitrite [Presence] in Urine by Test strip
2016
17430
1.28
14.55
4.9
4.0
estimate
0.0
0.0
1.08
485
3755
(3018095) Leukocytes [#/volume] in Urine
1295
10569
1.31
14.54
4.6
3.0
e6/l
39.6
57.4
1.08
936
6529
(3016502) Oxygen saturation in Arterial blood
254
1508
1.72
14.46
8.7
8.9
%
96.5
96.7
0.15
241
1431
(3029634) Reagin Ab [Titer] in Serum by VDRL
180
963
1.90
14.44
2.5
1.9
titre
4.4
10.9
—
5
23
(3007461) Platelets [#/volume] in Blood
4409
42787
1.96
14.44
19.0
12.8
e9/l
263.0
260.3
2.32
4335
41929
(3015377) Calcium [Moles/volume] in Serum or Plasma
983
7728
1.35
14.26
3.1
2.5
mmol/l
2.3
2.3
0.11
885
7019
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
165
863
1.95
14.17
9.9
10.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
739
5559
1.39
14.14
2.4
2.5
u/l
7689.9
6870.3
0.24
267
2410
(3026361) Erythrocytes [#/volume] in Blood
4414
42882
1.96
13.94
18.9
12.8
e12/l
4.6
4.6
1.27
4332
41993
(3000963) Hemoglobin [Mass/volume] in Blood
4416
42910
1.97
13.90
19.1
12.9
g/l
137.6
138.1
1.65
4374
42512
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
64
224
2.88
13.77
1.4
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
4412
42869
1.94
13.72
18.9
12.7
pg
29.9
29.9
0.02
4370
42478
(3024731) MCV [Entitic volume]
4412
42872
1.94
13.67
18.9
12.7
fl
89.2
89.0
2.34
4371
42483
(3014576) Chloride [Moles/volume] in Serum or Plasma
337
2184
1.59
13.63
8.4
7.3
mmol/l
104.0
105.0
4.00
327
2141
(3010813) Leukocytes [#/volume] in Blood
4414
42907
1.94
13.52
19.0
12.8
e9/l
7.2
6.8
27.80
4334
41988
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
566
4095
1.44
13.48
3.1
2.2
e6/l
0.8
1.1
0.68
309
2120
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
337
2193
1.58
13.39
1.9
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
110
506
2.20
13.34
8.1
3.6
nmol/l
1.1
0.9
1.78
93
436
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
927
7288
1.34
13.34
2.3
2.1
mg/l
2.7
2.5
1.14
786
6303
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
353
2332
1.56
13.13
3.2
2.4
—
—
—
0
0
(3044889) 12 lead EKG panel
2030
17708
1.26
13.13
2.7
2.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
877
6857
1.35
13.06
5.1
3.5
%
97.3
96.5
0.52
847
6649
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
550
3982
1.43
13.03
3.2
2.3
e6/l
4.6
4.0
0.58
297
2001
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
343
2256
1.56
13.01
1.8
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
1779
15298
1.27
12.90
2.4
2.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
139
711
1.99
12.76
4.3
3.8
mmol/l
24.5
24.8
0.64
134
682
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
23
40
5.77
12.72
3.7
3.2
mg/l
2.6
2.4
0.16
23
35
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
1629
13886
1.27
12.64
2.3
2.2
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
13
11
11.85
12.63
3.1
4.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1623
13838
1.27
12.54
3.5
2.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3532
33032
1.31
12.43
3.4
2.8
mmol/l
2.9
2.9
0.21
3320
31496
(3002173) Hemoglobin [Mass/volume] in Arterial blood
235
1425
1.68
12.41
9.0
9.2
g/l
121.2
126.2
2.58
224
1359
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
105
489
2.17
12.38
1.4
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
269
1690
1.63
12.38
8.2
7.1
mmol/l
1.3
1.4
1.21
263
1617
(3013512) EKG study
666
5036
1.38
12.22
2.8
2.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
83
352
2.38
12.21
4.4
4.9
u/ml
0.3
0.3
1.17
36
181
(3047181) Lactate [Moles/volume] in Blood
129
663
1.97
11.71
5.3
5.3
mmol/l
1.3
1.2
0.68
114
558
(3023511) Choriogonadotropin [Units/volume] in Urine
397
2757
1.48
11.67
1.5
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
116
579
2.03
11.44
5.9
5.9
umol/l
392.9
372.8
0.74
101
506
(3011648) Oxygen content in Venous blood
47
154
3.07
11.41
3.9
3.9
%
11.9
11.9
0.02
47
154
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
180
1039
1.76
11.37
2.0
1.4
u/ml
117.4
101.5
1.26
33
238
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
125
646
1.96
11.19
4.2
2.7
mmol/l
24.1
24.3
0.41
118
607
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2991
27543
1.25
11.10
3.4
2.6
u/l
37.1
31.8
5.95
2876
26591
(4035726)
237
1484
1.63
11.07
1.6
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
930
7488
1.30
11.06
8.6
6.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
184
1079
1.73
11.01
1.9
1.4
u/ml
20.5
18.2
—
6
27
(44816559) Phosphatidylethanol [Mass/volume] in Blood
189
1118
1.72
10.96
1.7
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
115
586
1.99
10.73
6.2
5.9
%
0.9
1.0
0.64
106
534
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
144
794
1.84
10.61
10.1
11.0
mmol/l
23.4
23.8
0.60
134
747
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
115
589
1.98
10.59
5.9
5.9
%
2.2
1.9
1.47
106
534
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
255
1656
1.57
10.25
4.6
2.9
mmol/l
1.2
1.2
0.74
230
1412
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
119
626
1.93
10.15
2.7
2.5
ug/l
270.8
784.1
0.65
107
555
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
183
1098
1.69
10.10
2.0
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
158
913
1.76
9.98
5.0
5.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
916
7455
1.29
9.91
3.6
2.9
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
68
292
2.35
9.80
3.0
2.4
%
0.9
1.2
0.75
47
235
(3020630) Protein [Mass/volume] in Serum or Plasma
171
1016
1.71
9.80
2.2
1.8
g/l
67.3
67.8
0.36
163
964
(3000570) Elastase.pancreatic [Mass/mass] in Stool
113
592
1.93
9.77
1.6
1.3
ug/g
300.2
322.2
0.52
73
278
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
73
324
2.27
9.76
2.4
1.8
iu/ml
394116.7
2128906.0
—
9
33
(3042517) Benzodiazepines panel - Urine
43
147
2.94
9.75
4.0
2.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
727
5753
1.31
9.71
1.3
1.3
iu/ml
24.5
19.5
0.68
199
1590
(3015235) Bicarbonate [Moles/volume] in Capillary blood
94
464
2.05
9.62
3.7
2.5
mmol/l
23.4
23.7
0.32
82
415
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
32
92
3.50
9.60
1.8
1.6
u/l
5.2
3.1
0.32
18
49
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1277
10859
1.24
9.48
1.4
1.3
u/ml
1.3
1.6
0.54
363
3149
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
340
2394
1.45
9.31
4.5
3.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
881
7186
1.28
9.31
2.1
1.9
mg/l
1.0
0.9
0.26
614
4889
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
382
2753
1.42
9.23
3.9
2.5
u/l
38.9
52.9
0.36
338
2361
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3488
32941
1.25
9.07
3.4
2.7
mmol/l
4.7
4.7
0.25
3324
31653
(3005719) IgG [Mass/volume] in Serum or Plasma
356
2547
1.43
8.95
2.8
2.4
g/l
10.6
10.5
0.32
336
2350
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
119
654
1.84
8.92
1.5
1.6
mmol/l
10.5
11.5
0.38
23
69
(3000764) Benzodiazepines [Presence] in Urine
646
5085
1.32
8.92
2.9
2.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
253
1694
1.52
8.90
2.7
2.1
ml/min/173m2
77.8
87.9
1.70
80
600
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
94
478
1.99
8.89
1.9
1.9
ug/l
1.1
1.6
0.62
86
417
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
670
5308
1.31
8.82
1.3
1.3
u/ml
9.3
7.9
0.27
264
2244
(3028300) Cannabinoids [Presence] in Urine
649
5127
1.31
8.72
3.0
2.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
342
2448
1.43
8.58
1.4
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3465
32763
1.24
8.55
3.3
2.7
mmol/l
1.3
1.4
21.20
3296
31476
(3019225) pH of Specimen
268
1832
1.49
8.54
5.4
2.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
69
317
2.19
8.54
2.9
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
495
3782
1.35
8.38
3.1
2.4
ng/l
371.5
393.4
0.06
216
1575
(3039000) Anion gap in Blood
76
367
2.09
8.30
7.3
7.8
mmol/l
11.9
11.5
0.51
68
320
(3018572) Chloride [Moles/volume] in Blood
76
368
2.08
8.25
7.3
7.8
mmol/l
105.5
105.6
0.03
68
321
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3328
31377
1.23
8.21
3.1
2.5
mmol/l
1.3
1.2
13.76
3168
30175
(3037522) Nuclear Ab [Titer] in Serum
632
5015
1.30
8.19
1.4
1.4
titre
522.4
532.9
0.04
117
849
(3016879) Cocaine [Presence] in Urine
604
4772
1.31
8.08
3.0
2.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
155
949
1.66
8.00
6.7
7.3
mmol/l
23.3
23.9
0.92
141
872
(3027008) Opiates [Presence] in Urine
641
5117
1.29
7.93
2.9
2.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
515
4005
1.32
7.72
3.1
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
75
373
2.03
7.61
3.0
2.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
188
1222
1.56
7.60
1.5
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
180
1161
1.57
7.53
3.3
2.4
e6/l
0.2
0.2
0.43
172
1109
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
181
1169
1.57
7.53
1.5
1.3
u/ml
240.3
234.3
0.11
133
774
(3036481) Cortisol [Moles/volume] in Serum or Plasma
431
3280
1.35
7.49
2.1
1.9
nmol/l
366.5
385.8
1.32
401
3020
(3004588) Protein electrophoresis panel - Serum or Plasma
119
696
1.73
7.31
1.4
1.4
—
—
—
0
0
(4198724)
97
534
1.83
7.31
3.1
3.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
48
203
2.38
7.26
1.6
1.8
mg/l
61.3
34.6
1.60
36
169
(3027944) Amphetamines [Presence] in Urine
626
5047
1.28
7.14
2.9
2.3
—
—
—
0
0
(4010399)
231
1595
1.47
7.05
1.3
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
82
433
1.91
7.04
2.9
2.8
ug/min
311.8
150.6
0.99
68
292
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
132
804
1.66
7.00
1.2
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
70
351
2.01
6.98
1.3
1.4
g/l
10.5
10.7
0.15
64
305
(3041096) Erythrocytes [Presence] in Urine by Automated
1241
10798
1.21
6.97
3.1
2.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
48
208
2.32
6.89
5.6
7.0
mg/l
9.4
9.2
0.14
43
192
(40768804) Tissue Pathology biopsy report
1375
12088
1.20
6.89
1.9
1.8
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
33
119
2.79
6.89
2.0
4.9
mg/l
70.7
7028.1
1.35
22
80
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
74
381
1.96
6.85
1.3
1.4
g/l
3.6
3.7
0.22
60
275
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
74
381
1.96
6.85
1.3
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
148
934
1.60
6.83
3.8
3.0
g/l
0.9
0.3
1.50
95
475
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
74
382
1.95
6.80
1.3
1.4
g/l
7.5
7.0
1.59
63
296
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
47
203
2.33
6.80
1.7
1.8
mg/l
48.4
27.7
1.42
35
169
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1797
16187
1.18
6.78
2.0
1.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
61
294
2.09
6.77
1.3
1.3
g/l
38.2
39.9
1.03
56
267
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
117
698
1.69
6.72
1.1
1.2
iu/ml
61.1
2255.7
0.93
41
213
(3044640) Blood type and Crossmatch panel - Blood
1178
10231
1.20
6.70
2.5
1.9
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
267
1915
1.42
6.67
1.6
1.8
g/l
1.2
1.3
0.99
248
1794
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
142
894
1.61
6.62
3.1
2.6
ng/l
109.0
75.7
0.55
118
740
(3000093) Morphology [Interpretation] in Blood Narrative
44
188
2.35
6.54
1.3
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
369
1.94
6.42
1.3
1.4
g/l
3.3
3.0
1.11
61
292
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
179
1197
1.52
6.42
1.7
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
293
3932
0.73
6.39
1.5
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
2173
19951
1.17
6.35
2.3
2.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
75
400
1.89
6.29
2.5
2.8
umol/l
29.6
32.4
0.77
65
351
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
571
4622
1.27
6.28
1.5
1.5
pmol/l
156914245.9
24726366.1
1.73
499
4105
(3017354) Segmented neutrophils/100 leukocytes in Blood
41
173
2.38
6.28
2.7
2.3
%
52.7
56.4
0.44
24
113
(40761535) Cells panel - Urine sediment
246
1761
1.42
6.23
3.5
2.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
142
909
1.58
6.20
2.4
2.7
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
47
212
2.23
6.18
1.2
1.5
nmol/l
1.4
1.4
0.13
42
191
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
43
187
2.31
6.16
3.0
2.5
umol/l
162.4
144.5
0.13
20
85
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
55
265
2.09
6.14
1.1
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
154
2303
0.66
6.14
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
342
2594
1.34
6.10
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
153
1003
1.54
6.03
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
378
2924
1.32
5.89
1.5
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
179
1220
1.49
5.89
3.3
2.9
g/l
3.5
3.6
0.46
167
1149
(40760888) Immunoglobulin light chains.free panel - Serum
38
160
2.39
5.86
1.6
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
85
2.95
5.83
1.8
1.9
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
297
3920
0.74
5.81
1.5
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
187
1292
1.47
5.75
1.9
1.9
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
206
1453
1.44
5.69
1.8
1.7
iu/ml
1.8
0.4
0.45
41
295
(3007566) Smooth muscle Ab [Titer] in Serum
152
1009
1.52
5.68
1.2
1.4
titre
83.8
79.7
0.09
13
114
(3016650) Hepatitis A virus Ab [Presence] in Serum
126
802
1.59
5.67
1.2
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
307
4018
0.75
5.67
1.6
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
55
274
2.02
5.65
1.1
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
181
1250
1.47
5.59
2.6
2.5
%
96.0
94.9
0.25
164
1137
(36660697) Celiac disease serology panel - Serum
484
3897
1.27
5.56
1.2
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
249
1826
1.38
5.52
1.1
1.1
u/ml
1.2
12.3
—
5
21
(3007164) IgA [Mass/volume] in Serum or Plasma
1046
9126
1.19
5.51
1.4
1.4
g/l
2.2
2.1
2.76
650
6007
(3008116) Ketones [Moles/volume] in Urine by Test strip
20
62
3.24
5.44
1.7
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
43
198
2.18
5.43
1.7
1.7
ratio
1.5
1.2
—
5
30
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
152
1020
1.51
5.42
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
751
6367
1.21
5.38
2.8
2.8
ug/g
134.3
111.0
1.05
600
5050
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
154
1038
1.50
5.38
1.8
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
331
2548
1.32
5.36
3.1
2.4
%
29.2
31.4
3.04
266
2001
(3022217) INR in Platelet poor plasma by Coagulation assay
215
1547
1.41
5.34
10.1
7.0
inr
1.1
1.1
0.22
50
306
(40767503) Oxygen content in Capillary blood by calculation
77
438
1.77
5.32
3.0
1.8
%
17.5
18.0
0.68
39
195
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
79
453
1.76
5.31
12.6
11.6
mmol/l
0.6
0.6
0.10
71
416
(3013139) Helicobacter pylori Ag [Presence] in Stool
286
2159
1.35
5.29
1.3
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
425
3389
1.28
5.29
2.4
2.2
mmol/l
2.4
2.4
3.69
345
2896
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
871
7511
1.20
5.20
2.5
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
149
1009
1.49
5.11
2.2
1.9
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
13
31
4.20
5.09
26.3
7.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
115
737
1.57
5.07
1.2
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
388
4849
0.78
5.06
1.4
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
37
165
2.25
5.06
10.7
7.9
u/ml
336.5
14384.0
0.51
20
46
(3008757) Leukocyte morphology finding [Identifier] in Blood
42
198
2.13
5.03
4.0
2.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
62
337
1.85
4.99
1.4
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
21
71
2.97
4.98
1.3
1.5
e6/l
3583.8
3398.6
0.07
13
46
(3009445) Proteinase 3 Ab [Units/volume] in Serum
162
1125
1.46
4.91
2.3
1.8
u/ml
13.0
9.9
—
7
64
(3006184) Hemoglobin [Mass/volume] in Capillary blood
82
488
1.69
4.86
2.4
2.0
g/l
134.2
136.8
0.61
70
378
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
52
269
1.94
4.86
1.2
1.2
u/l
84.3
35.7
0.47
44
237
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
105
667
1.59
4.83
1.7
1.7
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
28
4.29
4.82
27.3
7.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
20
67
2.99
4.82
1.3
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
350
2759
1.29
4.78
2.2
2.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
394
4879
0.79
4.76
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
394
4875
0.79
4.73
1.4
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
308
3928
0.77
4.73
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
34
151
2.26
4.72
3.2
3.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
41
197
2.09
4.70
1.6
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
98
617
1.60
4.69
1.6
1.3
—
—
—
0
0
(3036489) Thrombin time
192
1389
1.40
4.66
2.5
2.3
s
21.4
20.6
1.37
157
1141
(3041806) Other cells [#/volume] in Blood by Manual count
27
613
0.44
4.66
1.4
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
208
1528
1.38
4.62
1.5
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
20
69
2.91
4.59
1.5
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
90
559
1.62
4.56
4.1
2.6
mmol/l
1.6
1.9
0.96
55
315
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
460
5570
0.81
4.55
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
395
4861
0.79
4.53
1.4
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
133
905
1.48
4.50
2.1
1.8
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
17
54
3.16
4.48
1.2
2.1
ng/l
95.9
20.1
0.67
11
27
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
24
93
2.59
4.46
2.2
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
69
402
1.73
4.45
1.4
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
372
2984
1.27
4.44
1.4
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
64
366
1.76
4.41
1.6
1.9
mu/l
81.8
65.3
0.32
56
325
(3052851) Hemolysis interference index of Serum or Plasma
113
747
1.53
4.40
2.5
2.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1021
9043
1.17
4.38
5.4
4.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
152
1072
1.43
4.29
1.2
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
58
325
1.79
4.29
1.2
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
18
61
2.96
4.27
1.4
1.6
e6/l
18787.9
12870.1
0.19
11
34
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
824
7187
1.18
4.27
2.0
1.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
428
5186
0.81
4.26
1.5
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
68
401
1.71
4.22
1.9
1.6
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
119
803
1.49
4.22
2.2
1.7
titre
3680.0
5089.2
—
6
26
(3040151) Glucose [Moles/volume] in Capillary blood
50
269
1.87
4.21
3.4
6.4
mmol/l
8.0
6.6
1.31
41
219
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
64
372
1.73
4.19
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
36
173
2.09
4.16
3.2
2.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
165
1189
1.40
4.14
3.2
2.8
%
178.7
160.0
1.92
158
1121
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1083
9677
1.16
4.10
1.7
1.6
—
—
—
0
0
(3000492) Spirometry study
477
3970
1.23
4.10
1.4
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
31
142
2.19
4.04
2.5
3.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
66
393
1.69
3.98
1.5
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
64
378
1.70
3.97
1.7
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
23
93
2.48
3.96
2.2
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
23
93
2.48
3.96
2.2
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
23
93
2.48
3.96
2.2
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
691
5980
1.18
3.92
1.7
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
82
519
1.59
3.90
1.9
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
17
59
2.89
3.89
1.5
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
271
3424
0.78
3.89
1.4
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1653
15246
1.13
3.88
1.8
1.9
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
31
145
2.15
3.85
1.2
1.4
pmol/l
13.5
13.4
0.07
22
125
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
41
214
1.92
3.81
1.7
1.7
%
39.4
48.5
0.72
30
143
(3010421) pH of Blood
98
650
1.52
3.81
4.2
2.9
ph
7.4
7.4
0.84
89
548
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
1035
9264
1.15
3.80
2.2
2.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
25
108
2.32
3.75
1.1
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
19
72
2.65
3.72
2.3
2.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
48
267
1.81
3.68
3.3
2.9
e6/l
756.3
881.6
0.64
17
109
(3007463) Buprenorphine [Presence] in Urine
18
67
2.69
3.65
3.9
6.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
36
183
1.97
3.62
1.1
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
58
347
1.68
3.48
1.2
1.6
pmol/l
324.2
401.1
0.87
44
261
(3035320) C reactive protein [Mass/volume] in Body fluid
43
236
1.83
3.46
2.9
2.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
31
152
2.05
3.45
3.3
3.7
mg/l
259.0
49.2
1.38
25
114
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
76
488
1.57
3.45
1.3
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
76
488
1.57
3.45
1.3
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
132
948
1.40
3.44
1.4
1.4
u/l
13.9
11.1
0.83
117
815
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
47
267
1.77
3.39
1.0
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
49
282
1.75
3.38
1.1
1.2
u/ml
1.4
14.3
—
5
36
(3003181) Sodium [Moles/volume] in Urine
36
189
1.91
3.33
1.4
1.6
mmol/l
86.5
74.3
0.45
28
149
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
119
845
1.42
3.32
2.8
4.1
ug/l
7.6
61.4
0.56
84
533
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
14
48
2.92
3.29
1.5
1.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
21
90
2.34
3.24
8.6
8.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
52
309
1.69
3.22
1.1
1.1
miu/ml
1632.1
1446.7
0.49
52
309
(3027923) C peptide [Moles/volume] in Serum or Plasma
28
136
2.07
3.21
1.6
2.3
nmol/l
1.4
1.4
0.03
21
112
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
46
265
1.74
3.19
2.0
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
106
744
1.43
3.17
4.4
3.6
%
58.8
56.2
1.95
106
744
(21494814) CD8 cells/100 lymphocytes in Specimen
25
117
2.14
3.15
2.4
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
414
3496
1.20
3.11
1.2
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
29
145
2.01
3.09
2.0
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
29
145
2.01
3.09
2.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
29
145
2.01
3.09
2.0
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
390
3278
1.21
3.08
1.2
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
14
50
2.81
3.08
1.6
1.5
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
6
8
7.51
3.05
2.3
10.8
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
74
488
1.52
3.03
1.2
1.2
—
200.0
—
0
11
(3051611) Lipemic interference index of Serum or Plasma
35
189
1.86
3.00
2.6
3.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
104
736
1.42
2.99
4.2
3.5
e9/l
4.6
3.9
2.40
104
736
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1532
14235
1.11
2.99
1.8
1.7
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
5
10.01
2.98
1.8
1.6
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
5
5
10.01
2.98
2.6
5.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
146
1096
1.34
2.95
2.5
2.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
13
46
2.83
2.91
1.0
1.0
umol/24h
0.6
0.7
—
7
30
(3045424) Erythrocytes [Presence] in Urine
72
479
1.51
2.85
1.4
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
148
1121
1.33
2.83
2.9
1.9
g/l
0.2
0.2
1.56
141
1072
(21494815) CD4 cells/100 lymphocytes in Specimen
53
329
1.62
2.82
2.9
2.4
%
35.3
45.6
—
6
54
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
65
2.47
2.78
3.7
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
65
2.47
2.78
3.7
2.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
79
539
1.47
2.78
4.4
2.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
46
277
1.67
2.76
2.3
2.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
29
152
1.91
2.74
1.1
1.3
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
14
5.01
2.72
1.0
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
330
2767
1.21
2.71
1.4
1.3
u/ml
208.4
264.3
0.75
300
2573
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
76
518
1.48
2.69
2.0
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
28
146
1.92
2.69
1.6
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
23
112
2.06
2.66
1.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
47
289
1.63
2.62
2.0
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
149
1144
1.31
2.62
2.9
1.8
g/l
1.2
1.1
1.30
143
1094
(3017446) Testosterone [Moles/volume] in Serum or Plasma
384
3277
1.19
2.61
2.1
2.2
nmol/l
12.1
12.3
0.18
337
2998
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
15
4.67
2.59
5.7
8.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
38
2.90
2.58
2.2
3.9
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
19
87
2.19
2.57
1.8
2.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3892
38137
1.14
2.56
13.8
9.3
%
40.8
40.9
0.57
3223
32848
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2093
19877
1.10
2.54
3.5
2.9
ug/l
82.1
66.5
2.86
1969
18975
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
34
194
1.76
2.50
1.1
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
24
122
1.97
2.50
2.3
2.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
63
421
1.50
2.48
5.7
2.9
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
11
39
2.82
2.47
1.3
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
54
351
1.54
2.42
1.9
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
313
2642
1.20
2.42
1.7
1.7
ug/l
0.8
0.9
3.52
285
2437
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
824
9056
0.89
2.40
1.5
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
55
360
1.53
2.39
3.3
2.6
e9/l
1.3
1.3
0.11
33
196
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
91
659
1.39
2.37
1.9
2.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
44
274
1.61
2.37
2.8
2.3
—
—
—
0
0
(3025315) Body weight
8
22
3.64
2.36
5.1
2.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
17
4.12
2.36
1.1
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
17
4.12
2.36
5.0
8.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
13
52
2.50
2.35
1.3
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
32
183
1.75
2.35
1.5
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
48
306
1.57
2.35
1.6
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
53
347
1.53
2.32
1.9
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
65
445
1.47
2.30
1.0
1.1
g/l
1.4
1.4
0.36
60
402
(3010144) Erythrocytes [#/volume] in Synovial fluid
24
126
1.91
2.30
1.5
1.5
e6/l
4755.3
33857.6
0.86
16
81
(1761868) Lipid panel - Serum or Plasma
1340
14319
0.91
2.27
2.1
1.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
53
349
1.52
2.26
1.9
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
53
349
1.52
2.26
1.9
1.4
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
28
156
1.80
2.25
1.1
1.2
g/l
0.3
0.3
1.00
21
120
(3008295) Osmolality of Serum or Plasma
36
216
1.67
2.25
1.6
1.9
mosm/kgh2o
290.6
287.9
0.24
30
169
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
54
359
1.51
2.21
1.9
1.4
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
24
128
1.88
2.21
2.8
2.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
21
107
1.97
2.20
1.4
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
12
48
2.50
2.18
1.6
1.3
pmol/l
501.9
252.6
—
7
34
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
48
2.50
2.18
1.3
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
42
2.62
2.18
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
15
67
2.24
2.17
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
35
563
0.62
2.16
1.1
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
50
329
1.53
2.16
2.1
1.7
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
14
4.29
2.15
1.0
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
19
3.69
2.15
3.6
3.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
16
74
2.17
2.14
2.8
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
81
587
1.39
2.13
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
74
529
1.41
2.11
1.5
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
68
2.21
2.10
3.1
2.6
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
22
116
1.90
2.10
1.0
1.1
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
8
25
3.20
2.09
1.3
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
53
356
1.49
2.09
1.5
1.3
—
24.6
—
0
7
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
844
9192
0.90
2.08
1.5
1.5
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
10
5.00
2.07
57.6
7.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
82
2.08
2.06
1.5
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
82
2.08
2.06
1.5
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
8
26
3.08
2.01
1.1
1.2
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
17
83
2.05
2.01
1.3
1.2
u/l
77.7
75.7
0.07
11
72
(3025130) Human papilloma virus identified in Specimen
124
969
1.29
1.99
1.8
1.8
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
106
811
1.31
1.99
1.7
2.1
mg/l
11.2
9.6
0.88
99
774
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
51
344
1.49
1.99
1.4
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
158
1274
1.25
1.97
2.0
2.0
u/l
40.0
40.0
0.01
151
1215
(3044007) Cell count panel - Peritoneal fluid
7
21
3.34
1.96
4.1
2.1
—
—
—
0
0
(3020891) Body temperature
83
614
1.36
1.95
4.4
5.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
17
84
2.03
1.95
1.9
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
17
84
2.03
1.95
1.9
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
20
105
1.91
1.95
1.5
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
14
64
2.19
1.94
1.3
1.2
—
35.0
—
0
6
(3000475) Leukocytes [#/volume] in Synovial fluid
55
380
1.45
1.91
1.6
1.8
e6/l
7330.6
14130.5
1.29
45
280
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
34
211
1.62
1.91
3.5
2.6
%
34.1
44.2
1.75
12
81
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
182
2202
0.82
1.90
1.3
1.2
ug/l
2.9
3.4
1.43
172
2112
(21494890) Protein electrophoresis panel - 24 hour Urine
16
78
2.05
1.90
1.4
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
28
165
1.70
1.90
1.1
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
229
1926
1.20
1.90
1.4
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
45
299
1.51
1.89
2.8
2.2
%
16.0
12.7
0.34
21
180
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
66
473
1.40
1.89
1.1
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
7
22
3.19
1.88
1.0
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
36
228
1.58
1.87
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
151
1220
1.25
1.86
1.3
1.3
—
—
—
0
0
(4146454)
22
122
1.81
1.83
4.0
3.0
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
42
278
1.52
1.81
1.1
1.4
—
193.3
—
0
9
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
53
2.27
1.80
1.1
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
53
2.27
1.80
1.1
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
53
2.27
1.80
1.1
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
53
2.27
1.80
1.1
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
7
23
3.05
1.80
2.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
53
369
1.44
1.79
1.2
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
446
3973
1.14
1.78
1.7
1.8
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
162
1327
1.23
1.78
1.6
1.7
mmol/l
7.8
7.4
0.79
79
809
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
305
2650
1.16
1.74
3.3
3.4
pmol/l
4.9
4.7
1.08
275
2401
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
74
2.03
1.74
2.9
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
74
2.03
1.74
2.9
1.9
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
16
81
1.98
1.74
1.3
1.2
u/l
14.1
14.5
—
10
66
(3014765) Yersinia sp identified in Stool by Organism specific culture
143
1160
1.24
1.72
1.2
1.1
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
5
13
3.85
1.71
1.0
1.1
mmol/l
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
25
148
1.69
1.70
1.9
1.7
%
48.5
39.7
0.47
16
96
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
43
291
1.48
1.69
1.9
2.0
%
100.6
99.5
0.07
38
259
(3024522) Salmonella sp identified in Specimen by Organism specific culture
50
349
1.44
1.68
1.9
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
36
235
1.54
1.67
1.9
1.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
110
869
1.27
1.67
1.2
1.5
e6/l
630.1
4600.6
0.46
94
710
(42529406) Shigella sp [Presence] in Stool by Culture
143
1165
1.23
1.67
1.2
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
209
1768
1.19
1.66
1.4
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
110
870
1.27
1.66
1.1
1.5
e6/l
10.5
24.9
1.32
89
680
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
21
119
1.77
1.66
7.1
4.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
271
2346
1.16
1.64
1.8
1.9
e9/l
4.3
4.3
0.00
227
2031
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
69
2.03
1.64
4.1
2.8
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
217
1845
1.18
1.64
2.3
2.3
umol/l
4.2
5.3
2.09
158
1376
(3011436) Histone Ab [Units/volume] in Serum
11
49
2.25
1.63
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
94
731
1.29
1.62
1.1
1.1
—
—
—
0
0
(4306422)
96
749
1.29
1.62
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
340
2997
1.15
1.61
1.1
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
5
14
3.57
1.61
1.2
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
20
3.00
1.58
2.0
2.4
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
7
26
2.69
1.58
1.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
18
99
1.82
1.57
1.1
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
140
1150
1.22
1.53
1.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
54
390
1.39
1.53
1.6
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
15
3.34
1.52
1.8
2.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
19
108
1.76
1.50
1.6
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
390
3490
1.13
1.49
4.2
3.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
296
3351
0.88
1.44
1.4
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
680
7348
0.91
1.44
1.3
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
22
2.73
1.43
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
133
1.66
1.42
2.2
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
174
1473
1.19
1.42
1.6
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
270
1.45
1.41
1.7
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
16
88
1.82
1.41
1.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
7
29
2.42
1.39
1.0
1.1
umol/24h
1.3
1.8
—
7
29
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
53
2.08
1.38
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
53
2.08
1.38
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
95
758
1.26
1.38
1.3
1.3
u/ml
3.1
4.0
0.73
52
336
(3039443) Prostate specific Ag panel - Serum or Plasma
20
323
0.62
1.36
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
155
1306
1.19
1.34
1.8
1.6
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
88
699
1.26
1.34
1.1
1.1
%
118.8
114.8
0.65
78
631
(3015171) Extractable nuclear Ab [Units/volume] in Serum
168
1427
1.18
1.33
1.3
1.3
u/ml
0.3
1.2
—
10
98
(40761995) Spermatozoa Progressive [#/volume] in Semen
38
535
0.71
1.33
3.5
3.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
38
535
0.71
1.33
7.0
6.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
21
128
1.64
1.33
1.5
1.5
nmol/l
136.8
131.8
0.25
21
128
(3005011) Chlamydia sp Ab [Titer] in Serum
12
61
1.97
1.32
1.4
1.5
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
15
83
1.81
1.31
3.1
2.5
umol/l
30.5
27.2
—
9
65
(3004982) Buprenorphine [Mass/volume] in Serum or Plasma
6
24
2.50
1.30
3.0
2.6
ug/l
2.5
2.0
—
6
18
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
64
490
1.31
1.29
1.3
1.2
umol/l
5.9
6.5
0.77
56
462
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
395
3573
1.12
1.28
2.1
1.9
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
99
1210
0.81
1.24
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
183
1577
1.17
1.24
1.1
1.1
u/ml
3.9
4.2
0.09
16
277
(3017569) Oxygen content in Arterial blood
9
45
2.00
1.23
3.9
3.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
58
442
1.32
1.22
2.2
1.7
iu/ml
57.7
27.4
—
6
24
(3044290) Cell count panel - Cerebral spinal fluid
101
825
1.23
1.22
1.2
1.5
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
63
486
1.30
1.22
1.1
1.1
%
94.8
93.3
0.17
58
454
(3016018) Differential panel - Cerebral spinal fluid
56
425
1.32
1.22
1.1
1.5
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
30
205
1.47
1.19
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
689
6428
1.08
1.19
2.1
2.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
26
2.31
1.18
6.8
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
250
2214
1.14
1.17
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
1499
14382
1.06
1.17
1.8
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
100
1211
0.82
1.16
1.1
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
80
642
1.25
1.15
1.3
1.3
u/ml
2.9
7.7
—
8
38
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
20
2.50
1.15
2.8
3.0
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
15
87
1.73
1.15
1.9
1.4
%
6.4
5.1
—
5
22
(3005082) Progesterone [Moles/volume] in Serum or Plasma
76
943
0.80
1.12
1.5
1.4
nmol/l
30.5
32.4
0.26
69
869
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
58
1.90
1.12
1.1
1.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
18
111
1.62
1.12
1.9
2.2
—
14.5
—
0
20
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
38
276
1.38
1.11
1.7
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
66
521
1.27
1.10
3.5
4.1
mmol/l
1.6
1.4
0.72
66
515
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
101
837
1.21
1.09
1.3
1.3
u/ml
8.7
17.7
0.74
17
119
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
46
346
1.33
1.09
1.2
1.2
ratio
1.1
1.1
0.02
18
134
(3003327) Ova and parasites identified in Stool by Light microscopy
202
1775
1.14
1.09
1.9
1.7
—
—
—
0
0
(4268621)
69
549
1.26
1.08
2.2
2.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
33
235
1.41
1.08
1.6
1.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
33
2.12
1.05
1.6
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
29
203
1.43
1.05
2.4
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
274
2463
1.12
1.04
1.1
1.1
titre
164.3
239.2
—
7
69
(3013762) Body weight Measured
5
22
2.27
1.03
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3724
37693
0.93
1.02
4.1
4.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
18
114
1.58
1.02
4.1
3.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
99
826
1.20
1.02
1.3
1.3
u/ml
5.8
5.3
0.06
15
72
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
47
1.92
1.02
1.1
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
10
53
1.89
1.01
1.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
35
2.00
1.00
2.9
1.5
ng/l
127.6
109.7
—
7
35
(3008536) Aspergillus sp Ab [Presence] in Serum
7
35
2.00
1.00
2.4
3.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
21
139
1.51
1.00
1.7
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
16
99
1.62
0.99
1.7
1.5
—
—
—
0
0
(4211845)
25
172
1.46
0.99
2.2
2.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
64
512
1.25
0.98
1.2
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
23
156
1.48
0.98
1.8
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
568
6073
0.93
0.97
1.4
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
43
328
1.31
0.95
1.6
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
21
141
1.49
0.94
1.5
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
124
1436
0.86
0.92
1.3
1.5
ug/l
0.4
0.4
0.33
47
441
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
34
252
1.35
0.91
2.2
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
37
278
1.33
0.91
1.3
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
184
1.42
0.91
1.0
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
56
446
1.26
0.91
3.3
4.2
u/ml
3.8
4.9
0.83
49
361
(3043409) Potassium [Moles/volume] in Arterial blood
56
446
1.26
0.91
3.4
4.3
mmol/l
3.8
3.8
0.15
50
414
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
108
921
1.18
0.90
1.3
1.3
u/ml
37.5
37.6
—
5
63
(44813793)
42
324
1.30
0.88
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
43
334
1.29
0.86
1.5
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
19
128
1.49
0.85
2.4
2.0
ml
2066.3
2176.0
0.13
19
123
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
12
72
1.67
0.85
2.6
2.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
37
282
1.31
0.85
1.8
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
21
145
1.45
0.84
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
43
335
1.29
0.84
1.5
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
45
1.78
0.84
1.0
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
322
2960
1.09
0.84
1.3
1.3
miu/ml
196.2
239.7
1.29
132
1464
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
33
248
1.33
0.83
1.0
1.1
%
103.8
92.1
1.43
26
198
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
28
205
1.37
0.83
1.0
1.1
%
109.9
96.5
1.39
14
87
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
39
301
1.30
0.82
3.6
2.7
e6/l
653.7
549.3
0.90
33
240
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
30
223
1.35
0.81
1.7
1.6
mg/l
14.4
26.1
1.59
11
64
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
12
73
1.65
0.81
2.6
2.5
mg/l
25.4
19.8
0.68
12
68
(44790047)
38
293
1.30
0.81
1.8
1.5
—
—
—
0
0
(44790048)
38
293
1.30
0.81
1.8
1.5
—
—
—
0
0
(44790049)
38
293
1.30
0.81
1.8
1.5
—
—
—
0
0
(44806118)
38
293
1.30
0.81
1.8
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
97
1.55
0.81
1.5
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
27
198
1.37
0.80
1.1
2.1
—
—
—
0
0
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
20.7
—
0
17
(3022670) pH of Venous cord blood
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
31
233
1.33
0.79
1.5
1.3
—
68.4
—
0
25
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
33
1.82
0.79
1.3
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
33
1.82
0.79
2.0
2.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
39
304
1.29
0.78
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
182
1.38
0.77
2.1
2.3
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.0
—
0.5
—
0
13
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
20
140
1.43
0.76
2.1
2.3
umol/l
26.2
26.8
0.11
20
135
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
10
59
1.70
0.75
1.1
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
59
1.70
0.75
1.2
1.2
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
25
183
1.37
0.75
2.0
2.0
umol/l
2.0
1.8
0.37
25
174
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
5
24
2.08
0.74
1.6
2.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
22
158
1.39
0.74
2.3
2.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
40
316
1.27
0.73
1.6
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
90
774
1.17
0.72
1.3
1.3
u/ml
2.5
5.0
1.02
38
267
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
14
92
1.52
0.72
1.1
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
44
353
1.25
0.71
1.7
4.5
u/ml
244.6
128.5
0.23
37
298
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
29
220
1.32
0.71
1.0
1.1
%
101.4
96.6
0.52
14
95
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
39
309
1.26
0.70
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
32
410
0.78
0.70
1.1
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
27
1.85
0.68
6.2
2.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
71
602
1.18
0.68
1.3
1.7
g/l
0.5
0.7
1.68
50
459
(3004451) EKG impression Narrative
7
42
1.67
0.68
1.0
1.2
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
5
91
0.55
0.67
1.0
1.0
u/ml
0.0
0.2
—
5
69
(3023410) Appearance of Cerebral spinal fluid
51
420
1.22
0.67
1.2
1.8
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
16
226
0.71
0.66
1.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
26
197
1.32
0.65
1.8
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
37
461
0.80
0.65
1.1
1.0
u/ml
0.4
3.1
1.32
12
110
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
23
171
1.35
0.65
1.9
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
7
44
1.59
0.65
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
11
70
1.57
0.65
1.1
1.7
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
36
286
1.26
0.65
1.4
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
15
103
1.46
0.65
1.6
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
14
95
1.48
0.64
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
41
332
1.24
0.63
1.4
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
11
71
1.55
0.62
1.1
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
16
113
1.42
0.61
1.1
1.1
—
—
—
0
0
(3007456) Orange IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
0.2
—
0
8
(3036071) Salmonella sp Ab [Titer] in Serum
22
165
1.33
0.60
1.1
1.1
—
—
—
0
0
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
0.2
—
0
10
(21494434) Karyotype in Bone marrow
15
105
1.43
0.60
1.6
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
41
335
1.23
0.59
1.1
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
8
52
1.54
0.59
1.3
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
24
183
1.31
0.59
4.6
2.9
u/ml
17.2
27.2
0.63
24
174
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
22
0.00
0.59
0.0
1.1
—
70.7
—
0
22
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
21
157
1.34
0.59
1.1
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
36
443
0.81
0.58
1.1
1.0
u/ml
0.3
4.0
1.17
12
123
(4024509)
28
219
1.28
0.58
1.3
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
35
1.72
0.57
1.5
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
59
502
1.18
0.57
1.1
1.2
mg/l
35.0
37.6
0.26
52
418
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
21
158
1.33
0.57
1.6
2.1
umol/l
12.9
13.6
0.13
21
158
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
27
211
1.28
0.57
2.1
2.3
mg/l
7.8
9.5
1.00
22
174
(4034850)
73
839
0.87
0.56
8.8
6.6
—
—
—
0
0
(4027681)
49
411
1.19
0.56
1.2
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
24
185
1.30
0.56
2.6
1.4
u/l
10.6
5.9
0.66
19
162
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
12
82
1.46
0.54
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
33
405
0.81
0.54
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
16
216
0.74
0.53
1.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
11
74
1.49
0.53
1.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
91
1.43
0.53
1.5
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
290
2720
1.07
0.52
1.8
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
19
249
0.76
0.52
1.1
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
98
0.61
0.52
1.2
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
64
1.41
0.51
1.1
1.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
41
489
0.84
0.51
1.3
1.3
pmol/l
76.3
65.6
—
8
128
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
85
958
0.89
0.51
1.1
1.0
u/ml
0.4
0.4
0.04
25
214
(3003338) MCHC [Mass/volume]
3563
35326
1.04
0.51
16.2
10.6
g/l
334.1
334.8
3.53
3539
35018
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
39
467
0.83
0.51
1.3
1.3
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
45
1.56
0.49
1.0
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
29
356
0.81
0.48
1.7
2.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
40
475
0.84
0.48
2.8
3.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
47
1.49
0.47
1.0
1.1
—
—
—
0
0
(44806071)
10
68
1.47
0.47
1.1
1.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
129
1411
0.91
0.46
1.7
1.6
nmol/l
0.7
0.5
0.31
111
1225
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
36
300
1.20
0.46
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
36
300
1.20
0.46
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
36
300
1.20
0.46
1.2
1.1
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
7
49
1.43
0.46
1.7
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
49
1.43
0.46
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
210
1960
1.07
0.46
2.6
2.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
83
0.60
0.45
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
36
301
1.20
0.45
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
36
301
1.20
0.45
1.2
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
107
1179
0.91
0.45
1.1
1.1
u/ml
4.4
5.1
0.13
53
507
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
37
438
0.84
0.44
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
36
302
1.19
0.44
1.2
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
51
1.37
0.44
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
197
1840
1.07
0.43
1.1
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
36
303
1.19
0.43
2.3
2.7
au/ml
157.3
134.8
—
6
42
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
56
1.43
0.42
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
70
622
1.13
0.42
3.5
2.7
mg/l
22.0
23.4
0.12
53
382
(3020356) Listeria sp identified in Specimen by Organism specific culture
12
87
1.38
0.42
1.3
1.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
44
378
1.17
0.42
1.2
1.4
g/l
0.4
0.4
0.15
24
263
(3027135) IgG subclass 1 [Mass/volume] in Serum
44
378
1.17
0.42
1.3
1.4
g/l
6.8
6.6
0.14
25
264
(3028192) IgG subclass 2 [Mass/volume] in Serum
44
379
1.16
0.41
1.3
1.4
g/l
3.6
3.0
0.86
25
266
(4062490)
44
379
1.16
0.41
1.3
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
8
59
1.36
0.41
1.3
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
27
222
1.22
0.41
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
204
1.23
0.40
1.1
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
54
474
1.14
0.40
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
171
0.76
0.39
1.2
1.6
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
35
1.43
0.39
1.6
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
120
1104
1.09
0.39
2.0
2.2
iu/l
3.4
4.3
1.29
47
464
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
19
0.00
0.39
0.0
1.1
—
36.6
—
0
19
(3034614) HLA Ag [Interpretation]
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
106
0.66
0.39
1.9
1.4
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
37
316
1.17
0.38
3.0
3.5
mg/l
8.7
8.5
0.04
31
253
(3047007) Chlamydophila sp Ab [Presence] in Serum
62
696
0.89
0.38
1.3
1.2
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.1
u/ml
0.0
9.8
—
5
31
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
89
1.35
0.37
1.2
1.2
—
—
—
0
0
(4094501)
28
332
0.84
0.36
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
90
1.33
0.35
1.2
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
16
201
0.80
0.35
1.1
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
80
0.62
0.35
2.0
1.9
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
16
126
1.27
0.35
1.1
1.1
%
83.0
76.1
—
5
26
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
44
1.36
0.34
1.0
1.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
16
127
1.26
0.33
1.1
1.1
%
78.0
90.3
—
5
26
(3009214) Lutropin [Units/volume] in Serum or Plasma
281
2683
1.05
0.33
1.5
1.4
u/l
8.4
7.4
0.87
231
2241
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
83
759
1.10
0.33
1.2
1.3
u/ml
41.3
32.5
—
10
64
(3036048) Francisella tularensis Ab [Titer] in Serum
6
90
0.67
0.32
1.3
1.1
—
173.3
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
(4281824)
20
165
1.21
0.31
1.1
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
23
193
1.19
0.30
1.4
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
127
1357
0.93
0.30
1.4
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
102
1098
0.93
0.30
1.1
1.1
u/ml
5.1
5.7
0.15
50
497
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
77
1.30
0.26
2.0
1.5
ug/l
8.1
7.9
—
10
77
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
80
862
0.93
0.25
2.1
2.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
76
1.18
0.24
1.6
3.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
158
1659
0.95
0.24
1.7
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
35
391
0.89
0.23
1.1
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
17
143
1.19
0.23
1.5
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
11
136
0.81
0.23
1.2
1.3
u/l
177.6
186.4
0.44
11
136
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
33
294
1.12
0.23
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
39
1.28
0.23
1.4
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
47
514
0.91
0.22
1.3
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
395
3843
1.03
0.22
1.7
1.6
mu/l
287.0
292.0
0.14
349
3440
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
96
904
1.06
0.21
2.4
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
30
336
0.89
0.21
1.2
1.2
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
11
0.00
0.21
0.0
3.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.1
—
116.5
—
0
11
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
211.5
—
0
11
(3025296) Carrot IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
6.0
—
0
5
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(4133840)
16
135
1.19
0.21
1.1
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
3.5
—
0
12
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
12
145
0.83
0.21
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
111
1052
1.06
0.21
3.5
2.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
89
1.24
0.21
2.1
1.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
11
89
1.24
0.21
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
61
566
1.08
0.20
1.3
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
46
499
0.92
0.19
2.4
1.6
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
16
137
1.17
0.18
1.6
1.5
u/field
1.8
5.1
—
9
103
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
116
1215
0.95
0.18
1.2
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
7
59
1.19
0.18
1.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
19
166
1.15
0.18
1.5
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
257
2496
1.03
0.17
2.2
2.2
au/ml
9.5
18.8
2.91
18
230
(3000060) B lymphocytes [#/volume] in Blood
18
157
1.15
0.17
2.9
2.3
e6/l
226.0
190.4
—
10
77
(3044009) aPTT.lupus sensitive (LA screen)
7
63
1.11
0.17
1.3
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
23
205
1.12
0.17
1.1
1.1
u/ml
0.5
7.4
1.18
16
127
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
36
331
1.09
0.16
1.1
1.1
u/l
1.0
1.0
0.01
14
126
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
56
525
1.07
0.16
1.2
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
9
78
1.15
0.15
1.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
93
1.18
0.14
2.1
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
34
314
1.08
0.14
1.2
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
152
1569
0.97
0.13
1.2
1.1
u/ml
3.4
1.4
1.05
75
686
(4038314)
17
151
1.13
0.13
1.2
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
110
0.82
0.13
1.0
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
23
252
0.91
0.12
1.0
1.1
u/ml
10.4
7.4
—
6
33
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
85
1.18
0.12
1.1
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
135
1392
0.97
0.12
1.1
1.1
u/ml
3.1
2.4
0.23
38
377
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
239
2338
1.02
0.12
1.3
1.2
au/ml
32.9
38.0
—
5
73
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
13
147
0.88
0.11
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
13
147
0.88
0.11
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
13
147
0.88
0.11
1.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
13
147
0.88
0.11
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
198
1934
1.02
0.11
1.8
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
12
105
1.14
0.11
2.4
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
10
86
1.16
0.11
4.7
3.4
u/ml
16.2
44.6
—
10
86
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
21
192
1.09
0.10
3.1
2.3
%
31.7
28.1
0.63
21
185
(3006245) CD3-CD19+ cells/100 cells in Blood
22
202
1.09
0.10
3.0
2.4
%
9.0
9.4
0.06
22
195
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
27
289
0.93
0.09
1.5
1.2
u/ml
0.4
0.6
0.26
13
83
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
27
252
1.07
0.09
1.1
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
97
1.13
0.09
2.1
1.4
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
14
126
1.11
0.09
2.1
1.1
%
94.8
89.6
0.23
14
126
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
126
1.11
0.09
1.9
1.1
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
7
64
1.09
0.08
1.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
212
2156
0.98
0.08
1.5
1.6
mg/l
4.7
3.5
1.20
150
1358
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
67
1.04
0.08
1.4
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
136
1331
1.02
0.07
1.1
1.1
u/ml
1.9
1.3
0.20
72
610
(3014051) Protein [Presence] in Urine by Test strip
63
652
0.97
0.07
2.3
1.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
120
1228
0.98
0.07
1.4
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
23
215
1.07
0.07
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
118
1.10
0.07
1.2
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
8
91
0.88
0.06
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
48
498
0.96
0.06
1.0
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
305
3019
1.01
0.05
1.4
1.4
iu/l
13.8
11.8
0.68
242
2536
(3020650) Glucose [Presence] in Urine
13
141
0.92
0.05
1.8
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
31
323
0.96
0.05
1.7
1.7
mmol/l
6.7
5.7
1.09
25
287
(3038177) Helicobacter pylori Ab [Presence] in Serum
79
806
0.98
0.04
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
436
4389
0.99
0.04
1.5
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
91
1.10
0.04
1.5
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
17
180
0.94
0.04
7.2
8.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
67
657
1.02
0.03
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
393
3910
1.01
0.03
1.3
1.2
iu/ml
186.3
147.5
0.94
138
1464
(3003888) Timothy IgE Ab [Units/volume] in Serum
143
1416
1.01
0.02
1.1
1.1
u/ml
6.7
7.6
0.25
87
828
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
41
400
1.03
0.02
3.7
4.4
u/ml
55.8
106.0
0.69
15
131
(1761482) Bacteria [#/volume] in Urine by Culture
38
371
1.02
0.02
5.2
2.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
196
1948
1.01
0.02
1.6
1.6
%
19.5
23.8
0.82
17
221
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
25
243
1.03
0.01
2.6
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
130
1308
0.99
0.01
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
114
1.05
0.00
1.6
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
16
154
1.04
0.00
1.6
1.9
u/field
1.4
2.5
—
9
86
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
118
1.02
0.00
1.1
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
14
138
1.01
0.00
1.5
2.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
40
398
1.01
0.00
1.3
1.4
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
23
225
1.02
0.00
1.1
1.1
u/ml
22.0
10.5
—
9
50
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
134
0.97
0.00
1.1
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
89
889
1.00
0.00
1.1
1.1
u/ml
1.5
2.8
2.72
35
525
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
90
901
1.00
0.00
1.6
1.6
mmol/l
6.5
6.4
0.20
61
628
(4212803)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
9
0.00
0.00
0.0
1.1
—
9.0
—
0
9
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
85
0.94
0.00
2.5
4.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045759) Histamine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.8
—
1132.3
—
0
5
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
8
86
0.93
0.00
1.5
1.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014178) Parietal cell Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
9
0.00
0.00
0.0
1.1
—
53.8
—
0
9
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
5
53
0.94
0.00
1.0
1.1
—
9.0
—
0
7
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
55
0.91
0.00
1.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
80
1.00
0.00
1.0
1.1
—
—
—
0
0
(3000219) Insulin receptor Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
59
1.02
0.00
1.2
1.2
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
5
0.00
0.00
0.0
1.8
—
12.6
—
0
5
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
8
0.00
-0.00
0.0
1.0
—
136.9
—
0
8
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: K11_PARODON_EARLY – Parodontitis, under 40 years

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).